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Introduction: 
  Epilepsy is a chronic non-communicable disorder of the brain that affects people of all 
ages.  Approximately 50 million people worldwide have epilepsy, making it one of the most 
common neurological diseases globally.  Nearly 80% of the people with epilepsy live in low and 
middle-income countries.  People with epilepsy respond to treatment approximately 70% of the 
time.  About three fourths of people with epilepsy living in low and middle income countries do 
not get the treatment they need.1  
Epilepsy is the second common neurological disorder in India.  In the 70% of the 
population with epilepsy there is high prevalence in children about 0.8%   and it can affect 1 
person in 200 of people.2  
According to WHO people with epilepsy disorder in the growing countries, not getting 
proper treatment.3 
It is a neuropsychological disorder which occurs due to over discharge of 
neurotransmitter substance.  Some of reasons are common in epilepsy due to scaring tendency, 
chemical and hormonal imbalance, tumours or brain damage. It also includes sensitivity and low 
threshold of brain to epilepsy produces that epilepsy.  And it can affect the people at any age, 
sex, and race at any part of the life.4 
The common cause of epilepsy is exactly not known.  It may due to various reasons 
including trauma during birth process, head injury, childhood fevers, brain tumours, meningitis 
or drug induced. Genetic inheritance of single gene defects account for epilepsy in a small 
percentage of patients. 
A seizure usually occurs in the duration of few minutes mostly the persons recovers 
quickly. Despite regular treatment, 20-30% of the epileptic patients continue to have epilepsy 
seizure and they required to treated with two or more antiepileptic drugs.5 
The alternative drug therapy for the management of this disease can be by the use of 
medicinal plants and their active principles. Control to seizures numerous conventional drugs 
came into existence. Most of the epileptic patients need polytherapy of conventional 
anticonvulsants and still not 100% cured.6  
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 Antiepileptic drug therapy is the mainstay of treatment for most patients with recurrent 
seizures. The antiepileptic drugs act by three basic mechanisms, 
 Increased activity of GABA   
 Decreased glutamate activity and  
 Modification of ionic conductance.  
Approximately one-third of the patients develop refractory epilepsy requiring treatment 
with a combination of two or more antiepileptic drugs.7 
So now a day we are focussing herbal medicines to get relief with the symptoms of 
epilepsy. The medicinal plants for the study were selected in such a way that their availability is 
maximized in many parts of the world.8 
World Health Organization (WHO) estimates that 4 billion people, 80 percent of the 
world population, presently use herbal medicine for some aspect of primary health care.9 
The literature reveals that plants contain a large diversity of natural products that have 
demonstrated antiepilepsy are like  Erythrophleum ivorense,  Hypericum perforatum, Piper 
methysticum, Actaea racemosa10-13 
The plant Cassia alata Linn belongs to family Caesalpiniaceae. It is commonly known as 
ringworm senna.  It is used for treatment of ringworm, scabies, ulcers, and skin disease such as 
pruritis, eczema and itching. In the present study, antiepileptic potential of alcoholic extracts of 
leaves of Cassia alata have been evaluated. 
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2. LITERATURE REVIEW 
 
2.1 DEFINITION:  
 Epilepsy is a chronic disorder of the brain that affects people worldwide. It is 
characterized by recurrent seizures, which are brief episodes of involuntary movement that may 
involve a part of the body (partial) or the entire body (generalized), and is sometimes 
accompanied by loss of consciousness and control of bowel or bladder function.  
Epilepsy is a neurological disorder – a physical condition – which causes sudden bursts 
of hyperactivity in the brain. This hyperactivity produces “seizures” which vary from one person 
to another in frequency and form.  A seizure may appear as  
 • Brief stare  
 • Change of awareness  
 • convulsion.14 
Seizure episodes are a result of excessive electrical discharges in a group of brain cells. 
Different parts of the brain can be the site of such discharges. Seizures can vary from the briefest 
lapses of attention or muscle jerks to severe and prolonged convulsions. Seizures can also vary 
in frequency, from less than 1 per year to several per day. 
 
 
Figure 1:    
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2.2 EPIDEMIOLOGY 
 
One seizure does not signify epilepsy (up to 10% of people worldwide have one 
seizure during their lifetime). Epilepsy is defined as having 2 or more unprovoked seizures.  
Epilepsy is one of the world’s oldest recognized conditions, with written records 
dating back to 4000 BC. Fear, misunderstanding, discrimination and social stigma have 
surrounded epilepsy for centuries. This stigma continues in many countries today and can 
impact on the quality of life for people with the disorder and their families.1 
 About 50 million people worldwide have epilepsy and 90% of them 2 are from 
developing countries.14 
 Some medical conditions may cause seizures, these include: febrile seizures (caused 
by high fever in children), withdrawal seizures, and seizures caused by poisoning, allergic 
reaction, infection, or an imbalance of body fluids or chemicals (low blood sugar). These are 
not considered to be forms of epilepsy15 
Figure 2: 
 
Incidence is a measure of the number of new cases of a medical condition that occur in 
the population during a measured amount of time, usually one year. There are approximately 
200,000 new cases of seizures and epilepsy that occur each year.  The lifetime incidence of 
seizures is about 5% to 10%. Prevalence is the total number of existing cases of a disease in a 
specific population at a stated point in time. The prevalence of epilepsy is 2.7 million Americans 
of all ages. Males are somewhat more likely to have seizures than females. Approximately 10% 
of Americans will have a seizure in their lifetime. Every year about 300,000 people have the first 
seizure in their life time.16 
Evaluation of Anti-Epileptic Activity of Ethanolic Extract of Leaves of Cassia alata Linn. By 
Maximal Elecroshock (MES) and Isoniazid induced convulsions on mice 
 
Department of Pharmacology Page 5 
 
Figure 3: 
 
Epileptic seizures vary in severity and frequency, some people may experience no more 
than 2-3 seizures during their entire lifetime, others will have several seizures in one day.17 
 
2.3 ETIOLOGY: 
 In approximately 60-75% of all cases, there is no known cause. Of the remaining cases, 
there are a number of frequently identified causes. 
Identifiable Causes  
• Brain injury to the fetus during pregnancy  
• Birth trauma (lack of oxygen)   
• Head trauma (car accident, sports injury, shaken baby syndrome)  
• Substance abuse  
• Alteration in blood sugar (hypoglycemia)  
• Other metabolic illness (hypocalcemia)  
• Stroke14 
• Unknown  causes 
• Vitamin deficiency 
 (e.g., pyridoxine deficiency) 
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• Hypoxic-ischaemic encephalopathy 
• Hypotensive syndromes (Shock, Stokes- Adams attacks, vasodepressor syncope) 
• Drugs- Therapeutic (e.g., penicillins imepenem, isoniazid, phenothiazines, 
meperidine, theophylline, cyclosporine 506 [tacrolimus] 
• Drugs- Recreational (e.g., cocaine) 
• Alcohol withdrawal 
• Sedative drug withdrawal 
• Environmental toxins (e.g., lead, mercury, arsenic, strychnine, thallium) 
• Hypertensive encephalopathy 
• Endocrine 
 Thyrotoxicosis 
 Hypothyroidism 
• Eclampsia 
• Organ Failure: 
 Hepatic failure 
 Renal failure 
• Fever 
• Metabolic 
 Hypoglycemia 
 Hyponatremia/hypernatremia 
 Hypocalcemia 
 Hypomagnesemia  
 Alkalosis 
• Cerebral infections  
 Meningitis  
 Encephalitis  
 Abscess  
 Neurosyphilis  
• Toxins/poisons  
• Brain tumour/lesion18 
•  Cerebral vascular diseases 
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 Thrombosis 
 Embolism  
 Hemorrhage 
 Vasculitis  
 
 Figure 4:  
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Figure 5: 
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2.4 Diagnosis: 
1. CT scan 
2. EEG 
3. MEG/MSI  
4. MSRI 
5. PET 
6. MRI 
7. Functional MRI 
8. SPECT14  
 
2.5 Pathophysiology 
Epileptic seizures arise from an excessively synchronous and sustained discharge of a 
group of neurons. The single feature of all epileptic syndromes is a persistent increase of 
neuronal excitability. Abnormal cellular discharges may be associated with a variety of causative 
factors such as trauma, oxygen deprivation, tumors, infection, and metabolic derangements. 
However, no specific causative factors are found in about half of the patients suffering from 
epilepsy19. 
A seizure is produced when neurons within an area of the brain are activated in an 
unusually synchronous manner. Focal activation of a group of neurons may subsequently spread 
to involve nearby or distant neurons in an abnormal activation pattern. Any event, or 
combination of events, that disturbs the delicate balance between neuronal excitation and 
inhibition can produce a seizure20. Many different cellular or biochemical changes such as 
alterations in ion channel function, neurotransmitter level, and neurotransmitter receptor 
function, or energy metabolism may affect the excitability of neurons and produce seizures. In 
general, depolarization is mediated by synaptic currents generated by the excitatory 
neurotransmitters glutamate and aspartate21. Neuronal synchronization occurs through local 
enhancement of excitatory circuits.  An increase in synaptic efficacy is thought to be due to 
recruitment of N-methyl-D-aspartate (NMDA) receptors22. As more NMDA receptors are 
activated, further depolarization occurs, additional calcium enters the cell, and excitability is 
enhanced. As these excitatory processes increase, there may be a simultaneous reduction in the 
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activity of inhibitory circuits that are down-regulated during high-frequency activation23. 
Neurons can also be synchronized by extracellular currents that may reflect changes in the 
perineuronal environment, such as local edema, or changes in the extracellular potassium, 
calcium, or magnesium concentration24. Finally, neurons may also be synchronized by local 
ephaptic (non-synaptic) contacts, which facilitate the development of excitatory circuits25, 26. 
Fig 6: 
 
Neuroexcitability: The  presynaptic and postsynaptic neuron. Excitatory amino acids are released from the 
presynaptic terminal and act on postsynaptic NMDA and non-NMDA receptors (NMDAR) to cause excitation. 
GABA is an inhibitory neurotransmitter and acts on postsynaptic GABA receptors (GABAR). The glial cells 
play a central homeostatic role in the control of neuroexcitation by controlling extraneuronal potassium 
concentration and by removing excitatory neurotransmitters such as glutamate (Glu). Neuronal excitability 
may also be influenced by ions such as magnesium. 
 
 
blood–brain barrier due to infection, hypoxia, or alterations in cerebral blood flow autoregulation 
may allow passage of drugs and toxins into the CNS, thus influencing neuronal excitability (Fig. 
2). Changes in the integrity of the blood–brain barrier may also influence homeostasis within the 
neuronal microenvironment that is normally tightly regulated by the glial cell (Fig. 1). For 
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example, glial cells normally maintain a low concentration of extracellular Potassium27. 
Interruption of the blood–brain barrier may directly cause glial cell dysfunction or change the 
extracellular environment beyond its regulatory capacity. Glial cell dysfunction may lead to 
seizures by permitting a high ratio of extracellular to intracellular potassium, which depolarizes 
the neuronal membrane and increases neuronal excitability28. 
 
2.6 International classification: 
 The International League Against Epilepsy (ILAE) first published a classification system 
in 1960. The last official update for seizures was published in 1981, and the last official update 
for the epilepsies was in 1989. By definition, epilepsy is diagnosed after a patient has two or 
more unprovoked seizures. The 1981 and 1989 updates form the officially accepted classification 
system, although there continues to be efforts to develop a clinically meaningful revision to the 
current system. A report in 2010 by the ILAE Commission on Classification and Terminology 
recommended that changes be made in the current conceptualization, terminology, and 
definitions of seizures and epilepsy. This chapter will focus primarily on the currently accepted 
standard based on the 1981 and 1989 reports, and discuss the recommendations of the 2010 
ILAE report.29 
 GENERALISED SEIZURES: 
1. Absence seizures (petit mal) 
2. Myoclonic seizures 
3. Clonic seizures 
4. Tonic seizures 
5. Tonic clonic seizures (grand mal) 
6. Atonic seizures (drop attacks)  
 Typical absences  
 Atypical absences30 
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PARTIAL SEIZURES: 
1. Simple partial seizures (consciousness not impaired) 
a. With motor symptoms 
b. With sensory symptoms 
c. With autonomic symptoms 
d. With psychic symptoms 
2. Complex partial seizures (with impaired consciousness) 
a. Simple partial seizures followed by impairment of consciousness 
b. With impairment of consciousness at seizure onset 
3. Partial seizures evolving to secondarily generalized seizures 
a. Simple partial secondarily generalized  
b. Complex partial secondarily generalized  
c. Simple partial evolving to complex partial evolving to generalized.  
Sub categories: 
 The four main subcategories of seizure are: 
 Generalized seizures , affects entire brain 
 Partial seizures , affect the part of the brain 
 Non-epileptic seizures, caused by other thing such as diabetes, high fever, or other 
relevant causes.31 
I. GENERALISED SEIZURES: 
Generalized seizures (absence, atonic, tonic clonic and myoclonic) involve both sides of the 
brain, while partial (simple and complex) seizures involve only a part of the brain.  
1. Absence seizures:  
Formerly known as petitmal seizure. These seizures usually last from 2 to15 seconds and 
may occur just a few times a day,  or more than 100 times in a single day. They usually present 
as bland staring, which one might mistake for daydreaming, physical automatisms, such as lip 
smacking, fumbling or picking at clothes, or twitching of facial or body muscles.  Afterward, the 
person will likely have no memory of what happened while he or she had the seizure.  A lot of 
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people won’t recognize absence seizures as seizures. They occur mostly among children, starting 
between the age of 4 and 12.  They rarely begin after age 20. Most children with typical absence 
seizures are otherwise normal.  
2. Absence seizures with special features:  
Eyelid myoclonia with associated interruption of awareness is the characteristic seizure 
type in Jeavon’s syndrome. Myoclonic seizures (discussed below) can also be associated with 
momentary loss of awareness.32 
3. Generalized tonic clonic seizure:  
This type of seizure formerly known as grandmal seizures; also known as convulsions or 
convulsive seizures.  When most people think of seizures or epilepsy, they’re thinking of this 
type of seizure. When a person has a tonic clonic seizure, his or her arms and legs will first 
stiffen.  This is the tonic stage. His or her limbs and head will then begin jerking, which is the 
clonic phase.  Like all seizures, Generalized Seizures these can vary, mostly with people 
experiencing either the tonic or clonic phase by itself. During the seizure, the person might bite 
their tongue or the inside of his or her mouth, experience incontinence, or even decrease or cease 
his or her breathing (in this case, his or her breathing should return to normal during the tonic 
(jerking) portion of the seizure). Afterward, the person will likely be confused, not remember 
what happened, need to sleep for a while and might have a headache. Depending on the person, it 
can take them from minutes to hours to fully recover. For people with tonic clonic seizures, it is 
especially important to make sure that those who spend much time around them know correct 
seizure first aid. Some people bite their tongue or lose control of their bladder during the 
seizure.33 
During this seizure a person will usually emit a short cry and fall to the floor. This cry does 
not indicate pain. 14 
In its classic form, this seizure is a sequence of events that often begins with bilateral 
myoclonic jerks. This is then followed by a tonic contraction of the extremities and axial trunk 
muscles, resulting in extension of the neck and extension of the extremities. The tonic 
contraction of the diaphragm and abdominal and chest wall muscles against the contracted glottis 
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causes the characteristic tonic cry. The patient may become cyanotic during this phase. The 
generalised tonic activation can only be sustained for a short period of time.32 
4. Myoclonic seizures: 
These seizures cause parts of a person’s body to jerk for instance, his or her arm or leg 
might suddenly twitch. If you’ve ever had a foot twitch suddenly when you’re asleep, that would 
be a lot like a myoclonic jerk (but it does NOT mean you have epilepsy. The jerking of feet 
while you’re asleep is a type of non-epileptic behavior). Someone who has myoclonic seizures 
might be thought of as clumsy. First aid is usually not required for myoclonic seizures, but if it is 
your first seizure of this type, you might want to visit a physician to determine what is causing it.  
5. Atonic seizures: 
It is also known as drop attacks, or astatic or akinetic seizures.  Atonic seizures make 
your muscles suddenly relax.  This makes you fall down without warning33.  These seizures 
make a part, or all, of a person’s body suddenly go limp. This means that the person’s head 
might suddenly drop, or he or she could slump down or even totally collapse, dropping to the 
floor (thus the name drop attack). Because of the sudden and complete nature of these types of 
seizures, they can be dangerous to the person having one. This is why children and adults who 
experience these types of seizures sometimes wear protective headgear. To make matters worse, 
these types of seizures often won’t respond to epilepsy medications. No first aid is needed for a 
person having an atonic seizure, unless the person has hurt himself or herself during a fall, or if 
this is the first time he or she has had an atonic seizure. 
II. PARTIAL SEIZURES: 
(Simple partial seizures and complex partial seizures) are the most common type of 
seizures. They occur when only a part of one side of the brain is affected. With these seizures, 
the activity can start in one place in the brain, and then move to another, or it could just stay in 
the one area. Partial seizures affect whatever function the part of the brain they’re occurring in 
controls. If the seizure happens in the brain’s speech area, a person’s ability to talk will be 
affected. Almost any sort of movement or feeling can be a part of a partial seizure. If the seizure 
starts off as a partial seizure, then spreads to include the entire brain, it’s referred to as a partial 
seizure secondarily.31 
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Restriction for people with only simple partial seizures depends on the specific seizure 
manifestations (and, for driving, on regulations in a particular state). Partial onset seizures may 
progress to secondarily generalized seizures.34 
Partial seizures manifest themselves in many different forms, depending on which area of 
the cortex is involved in the onset and spread of the ictal discharge. Partial seizures originate 
from a focal area of cerebral cortex and may spread to other cortical regions either unilaterally or 
bilaterally.  A partial seizure may manifest with motor signs, autonomic symptoms, somato-
sensory or special sensory symptoms, or psychic symptoms. The term aura comes from the Latin 
word “breeze” and is synonymous with a simple partial sensory or psychic seizure. An aura often 
reflects the location of the seizure onset zone, although there is exceptions.29  
Simple partial seizures:   
A person having a simple partial seizure will often stay awake and aware throughout the 
seizure but, although they know what’s happening, are unable to speak and/or move until the 
seizure is over. Depending on the part of the brain affected during the seizure, the person might 
move uncontrollably. For instance, they might twitch, roll their eyes, shake their hands or feet or 
blink rapidly. These movements might start slowly, and then increase in rapidity or in the parts 
of the body involved. What starts as a hand bobbing up and down might evolve to an arm 
moving up and down, or even half of the body moving in a rhythmic manner. If the seizure 
affects a different part of the brain, the person’s emotions or senses might be affected instead. So 
they might have a feeling of déjà vu or that something terrible is about to happen. They might 
also suddenly become very angry or very happy. If their senses have been affected, they might 
hear, smell, taste, feel or see something that is not actually there. They might feel a breeze when 
they’re indoors; hear hearing, buzzing or talking that isn’t happening; think something is 
narrower or wider or closer or farther than it is. They could even hallucinate something from 
their past.  They might even burst out laughing or crying, and, like movement-oriented seizures, 
these seizures might start small or mildly and then increase in intensity. 
 Auras are simple partial seizures that may precede loss of consciousness (progression to a 
complex partial or secondarily generalized seizure).  People with particularly vivid or disabling 
complex partial seizures may also use this term to refer to the earliest and mildest ictal 
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symptoms. Many patients recognize the aura as a ‘warning’ that a larger seizure is about to 
occur. The aura may allow the patient to avoid injury or embarrassment by seeking a safe place 
to sit or lie down before the larger seizure occurs.34 
Complex partial seizures:  
These seizures affect a greater part of the brain than simple partial seizures and they also 
affect consciousness. Although they can affect any part of the brain, they generally take place in 
one of the brain’s two temporal lobes. Because of this, people prone to complex partial seizures 
are often said to have temporal lobe epilepsy (TLE). Usually, when a person has a complex 
partial seizure, they’ll stop what they’re doing and stare blankly at nothing in particular. They’ll 
stop interacting with their environment and with other people. (During simple partial seizures 
they can interact with other people).  They will then often start chewing, picking at their clothes, 
mumbling nothing in particular, performing repetitive motions, or any combination of these 
simple, unorganized movements. During complex partial seizures, people might appear 
conscious and normal because they’ll usually move about and remain standing with their eyes 
open—but they’ll be experiencing an altered consciousness. In other words, it’ll be rather like 
they’re dreaming or in a trance. If they talk, which they might be able to, they’ll likely not make 
sense—and they won’t be able to respond appropriately to others.31 
 Complex partial seizures impair consciousness and occur in all age groups.  Typically, 
staring is ac- companied by impaired responsiveness, cognitive function, and recall, although 
some degree of responsiveness may be preserved (e.g., orienting toward a stimulus).  Automatic 
movements (automatisms) are common and involve the mouth (e.g., lip smacking, chewing, 
swallowing), upper extremities (e.g., fumbling, picking), vocalization/verbalization (e.g., grunts, 
repeating a phrase), or complex acts (e.g., shuffling cards). More dramatic automatisms 
occasionally occur (e.g., screaming, running, disrobing, and pelvic thrusting). Complex partial 
seizures usually last from 15 seconds to 3 minutes. After the seizure, post-ictal confusion is 
common, usually lasting less than 15 minutes, although other symptoms, such as fatigue, may 
persist for hours.34 
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PHASES IN SEIZURES: 
Pre-ictal or prodrome: 
This is the time before the seizure. It can last from minutes to days and make people act 
and feel differently. Not everyone experiences something at this stage of a seizure. Some people 
who do experience a pre-ictal stage use it as a warning so they can prepare for the seizure. Of 
course, sometimes all it does is make you not feel very good for a few hours or a day before the 
seizure, while it doesn’t give you much of a clue about when the seizure will actually take place. 
Many people have an aura before a seizure. Technically, an aura is a simple partial seizure. 
Realistically, an aura might make you see, smell, hear or taste something for no reason. It can 
even just make you a bit nauseous, give you a weird feeling in your stomach, cause a ringing in 
your ears, or even just give you a funny feeling or a sense of déjà vu.35 
Status epilepticus: 
Seizures are almost always self-limiting. Rarely one may follow another in close 
succession (without complete recovery in between seizures), or the ictal activity may be ongoing.  
Status epilepticus has been traditionally defined as ongoing seizure activity for 30 minutes or 
more. However, most seizures self-limit within five minutes or less. From a pragmatic point of 
view, a seizure that lasts longer than five minutes often warrants pharmacological intervention.  
Status epilepticus refers to the situation in which a patient suffers from 2 or more 
generalised epileptic seizures without regaining consciousness between the seizures, or suffers 
from continuous partial seizures without clear cessation of epileptic activity between the 
seizures.  It is a medical emergency.36 
Ictal: 
This is the actual seizure. During this time there will be actual physical changes in the 
person’s body. After all, it’s at this point that the electrical storm in the person’s brain thunders 
to life. If the person with epilepsy were to be hooked up to any medical devices at this point, 
they’d show cardiovascular, metabolic and EEG changes. A lot of these changes will help a 
neurologist determine the seizure’s type and point of origin, both of which are very important in 
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treating the epilepsy.  We’ll cover the different types of seizures a person might experience when 
they’re ictal elsewhere in this pamphlet. 
Interictal:  
This is the time between seizures. A lot of people with epilepsy, including more than half 
of all people with temporal lobe epilepsy, suffer emotional disturbances between seizures. These 
disturbances range from mild fear to pathological levels of anxiety and depression. However, 
anxiety and depression are by far the most common, and these interictal problems are often more 
incapacitating and difficult to control than the seizures themselves. 
Co/ Inter-ictal: 
 This is the final phase, the often slow recovery period after a seizure. It can last from 
minutes to hours and vary quite a bit, partly depending on the type of seizure experienced, the 
intensity of it, and how long it lasted. It might leave the person feeling tired and/or bewildered, 
among other things, with a change in his or her consciousness or behavior. Sometimes symptoms 
from this phase can help doctors diagnose the part of the brain involved in the seizure. Many 
people will not remember anything that happened during the seizure.31 
Convulsive status: 
This is a state of recurrent tonic-clonic seizures without recovery of consciousness 
between attacks. It represents a medical emergency with a high morbidity and mortality. Status 
may occur in approximately 3% of people with epilepsy but it is most common in patients with 
severe epilepsy who are non-compliant with drug therapy. It may also occur in alcohol 
withdrawal, in acute meningitis or encephalitis, and in acute metabolic disturbances.    
Non-convulsive status: This term is used imprecisely for the following two very different 
scenarios:   
a) Motor manifestations in convulsive status inevitably cease at some point, however the 
cerebral cortex may continue to generate ictal discharges (no longer convulsive status 
epilepticus). This represents the most severe form of status, with ongoing excitotoxicity on a 
cellular level and high morbidity and mortality from a clinical perspective.    
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b) Ictal activity that from the onset was not associated with motor manifestations. 
Usually, the leading symptom is a change in the patient’s cognitive state (confusion, 
disorientation with subsequent amnesia). This kind of status epilepticus is thought to have focal 
origin, though this may no longer be evident once the ictal activity has been ongoing.    
Focal status:  
The ongoing seizure activity that defines status epilepticus may be restricted to a 
confined brain area. In this setting, the ictal symptoms reflect the cortical area affected (e.g. aura 
continua, aphasia). One classic example is epilepsia partialis continua of Kojevnikov. This refers 
to repetitive jerking of muscles or muscle groups in the face, arm or leg, originally described in 
association with epidemic encephalitis in Russia. Nowadays, the most common aetiologies are 
vascular disease, Rasmussen encephalitis, and tumours.  Relative frequency of seizure type’s 
data on the relative frequency of seizure types is unsatisfactory, and is largely based on 
populations of patients with relatively severe epilepsy, including large numbers of patients with 
partial epilepsies. Furthermore, the milder the epilepsy the more difficult it is to determine on 
clinical and electroencephalographic grounds whether it is of primary generalised or partial type. 
With these restrictions in mind, most series would suggest that approximately one-third of 
epilepsies may be of a generalised type, while two-thirds are partial, most commonly with a 
temporal lobe origin. 
Response to Medication: 
 On average, 70% of seizures are successfully controlled with one anti-epileptic 
medication. The remaining 30% of seizures are, thus far, resistant to medications. 
History of Medications: 
 For more than 100 years, various kinds of medications have been used to treat seizure 
disorders. 1861 – Bromides the first medication used to control of seizures. Side effects were 
severe. 1912 – Phenobarbital Effective, but sedating. 1936 – Phenytoin Known as the "miracle 
drug" of its day. Today – Many new medications are available, including a number approved 
since 1990. The Future – Research continues to be done in an effort to find a safe, effective anti-
convulsant. 14 
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2.7 SYMPTOMS: 
Almost all seizures are relatively brief, lasting from a few seconds to a few minutes. Most 
seizures last from 1 to 2 minutes.  When a seizure stops, people may have:  
• Headache  
• Numbness or tingling (pins and needles) in a specific body part  
• Confusion   
• Sore muscles  
• Unusual sensations (taste, smell, etc.)  
• Extreme tiredness  
• Loss of bowel or bladder control (soiling or wetting).37 
 
2.8 DISEASES, SYNDROMES, AND EPILEPSIES  
Disease versus syndrome: 
 Although there is reason to distinguish the concepts of disease and syndrome, these 
terms are not consistently used in medicine. Ultimately, it was decided not to insist on the 
disease–syndrome distinction in referring to the epilepsies at this time, although either or both 
terms have been and will continue to be used depending on the context and custom. Instead, 
there are at least three or four groupings that may be invoked in this context and as described 
below: Electro-clinical syndromes: Henceforth, the use of the term ‘‘syndrome’’ will be 
restricted to a group of clinical entities that are liably identified by a cluster of electro clinical 
characteristics. Patients whose epilepsy does not fit the criteria for a specific electro-clinical 
syndrome can be described with respect to a variety of clinically relevant factors (e.g., known 
etiology and seizure types). This does not, however, provide a precise (syndromic) diagnosis of 
their epilepsy.  
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Constellations:  
In addition to the electro clinical syndromes with strong developmental and genetic 
components to them, there are a number of entities that are not exactly electro-clinical 
syndromes in the same sense but which represent clinically distinctive constellations on the basis 
of specific lesions or other causes. These are diagnostically meaningful forms of epilepsy and 
may have implications for clinical treatment, particularly surgery.  These include mesial 
temporal lobe epilepsy (with hippocampal sclerosis), hypothalamic hamartoma with gelastic 
seizures, epilepsy with hemi convulsion and hemiplegia, and Rasmussen ‘‘syndrome.’’ Age at 
presentation is not a defining feature in these disorders, as we understand them; however, they 
are sufficiently distinctive to be recognized as relatively specific diagnostic entities. Whether or 
not they are considered ‘‘electro clinical syndromes’’ now or in the future is less important than 
that they be recognized by clinicians who are treating patients. Structural/metabolic epilepsies: 
The next group includes epilepsies secondary to specific structural or metabolic lesions or 
conditions but which do not, given our current understanding, fit a specific electro clinical 
pattern, although that may change in the future. Therefore, these entities represent a lower level 
of specificity than the two previous groups. Epilepsies of unknown cause: Those epilepsies, 
which in the past were termed ‘‘cryptogenic,’’ will now be referred to as being of ‘‘unknown’’ 
cause.38 
Rationalising the Use of Antiepileptic Drugs (AEDs)  
Most people can have their epilepsy controlled by one or, at the most, two AEDs.  If 
combination therapy is required, a second AED should be chosen which complements the first 
drug and attention should be paid to each one’s influence on the other’s metabolism.   
Monotherapy with the most appropriate AED should be pursued as far as possible before 
changing to or adding other agents.    
Care should be taken to find the minimum effective dose for any AED and to cease drugs 
which are clearly non-efficacious.  
A routine clinical review should be scheduled every three months for people using AEDs. 
A careful history and examination is more reliable in determining effectiveness and adverse 
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effects of treatment than drug serum levels in most situations. The exception is phenytoin, which 
can reach toxic levels with small dose increases. Monitor for adverse effects, which might 
indicate the need for dose reduction.39 
Possible adverse effects:  
 Ataxia  
 Dysarthria  
 Drowsiness  
 Nausea and vomiting 
 Skin rash  
 Decline in cognition 
 Agitation  
 Other disturbed behaviours 
 Gingival hypertrophy (overgrowth of gums) occurs in approximately 30% of people who 
use phenytoin.  
 Rare cases of fatal liver failure have been linked to valproate.  
 Vigabatrin and clonazepam may both stimulate aggression in people with developmental 
disabilities.  
 Many people who have developmental disabilities find it difficult to co-operate with 
sampling for blood tests.  
If a person has been seizure-free for 2-3 years at a constant level of AED, a very 
slow process of withdrawal of treatment may be undertaken.  The process is more likely 
to be successful if the EEG is normal, although this is by no means invariable and the 
decision to withdraw medication should be based on clinical judgement rather than the 
absence of EEG abnormalities.36 
First aid for convulsive epileptic seizures 
 Stay calm.  
 Note the time.  
 Prevent others from crowding round. 
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 Put something soft under the person’s head like a jacket to prevent injury. 
 Only move if they are in a dangerous place, such as in the road or at the top of stairs. 
Move things away from them if there is a risk of injury. 
 Do not attempt to restrain the convulsive movements. Allow the seizure to take its course. 
 Do not put anything in the person’s mouth. There is no danger of swallowing the tongue 
and teeth can easily be broken.17 
2.9 DIAGNOSIS METHODS: 
 No test can say for certain that you do or do not have epilepsy. But when the information 
from the tests is added to the description of what happens during your seizures, this builds up a 
clearer picture of what happened. 
This can help with the diagnosis and when choosing treatment. 
2.9.1 Electroencephalogram (EEG): 
 An EEG is used to record the electrical activity of the brain by picking up the electrical 
signals from the brain cells. These signals are picked up by electrodes on the head and are 
recorded on paper or on a computer.40 
The recording shows how the brain is working. Like an ECG, the electrodes only record 
electrical activity – they do not give out electrical signals and they do not hurt.  Before the test, 
the technician measures your head to work out where to place the electrodes.  Each electrode is 
held in place using a sticky paste. Once the electrodes are attached they are connected to the 
recording machine.  The test lasts about 30 minutes and you will probably be sitting or lying 
down.41 
An EEG gives information about the electrical activity of the brain during the time the 
test is happening.  When someone has an epileptic seizure their brain activity changes. This 
change, known as epileptic form brain activity, can sometimes be seen on an EEG recording. 
Some people can have epileptic form brain activity even when they do not appear to be having a 
seizure, so an EEG can be particularly useful for them.  Epileptic form activity can sometimes be 
provoked (brought on) by deep breathing.  The test may include deep breathing to see if epileptic 
form activity can be provoked and recorded.42 
Flashing lights during the EEG 
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Some people with epilepsy have seizures that are started, or ‘triggered’, by flashing 
lights.  This is called photosensitive epilepsy and it affects up to 5% (1 in 20) of people with 
epilepsy.  An EEG will usually include testing for photosensitive epilepsy. This involves looking 
at a light which will flash at different speeds.  If this causes any changes in your brain activity 
the technician can stop the flashing light before a seizure develops.43 
 
2.9.2 Magnetic Resonance Imaging (MRI) scans 
An MRI scan looks at the structure of the brain and may help to find the cause of your 
epilepsy.  During the scan detailed pictures are produced using strong magnetic fields. Because 
of the magnetic fields, metal objects in or near the machine can affect, or be affected by, the 
machine. 
Before having an MRI scan you will need to remove any metal objects such as jewellery, 
hearing aids, coins or keys. If you have a heart pacemaker or any surgical implant that contains 
metal you may not be able to have an MRI scan. The scanner makes a loud knocking noise, so 
before it starts you will be given earplugs to wear. You will also be given a buzzer to hold so you 
can let the technician know if you are uncomfortable or feeling unwell during the scan. 
The technician is usually on the other side of a window in another room during the scan, 
but an intercom means you can talk to them.  There is also a mirror inside the scanner so you can 
see the technician during the scan.  You may be able to have someone in the room with you 
during the scan.44 
 
2.9.3 Computerized Axial Tomography 
(CT or CAT) scan 
Some people may have a CT scan if they are not able to have an MRI scan. For example, 
if they have a heart pacemaker, if they might need to have an anaesthetic to have an MRI, or if 
information is needed quickly about what might be causing their seizures. 
CT scans use X-rays to take images of the brain.  (CT scans are not suitable if you are 
pregnant because the X-rays could affect an unborn baby).  Images from a CT scan are less 
detailed thanthose from MRI scans. During a CT scan you lie on a couch which slides into the 
scanner.  Unlike MRI scanners, CT scanners do not make a loud noise. 
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2.10 ROLE OF GABA: 
Figure 7:  
 
g-Amino butyric acid (GABA), the principal inhibitory neurotransmitter in the cerebral 
cortex, maintains the inhibitory tone that counterbalances neuronal excitation. When this balance 
is perturbed, seizures may ensue.45 GABA is formed within GABAergic axon terminals and 
released into the synapse, where it acts at one of two types of receptor: GABAA, which controls 
chloride entry into the cell, and GABAB, which increases potassium conductance, decreases 
calcium entry, and inhibits the presynaptic release of other transmitters. GABAA-receptor 
binding influences the early portion of the GABA mediated inhibitory postsynaptic potential, 
whereas GABAB binding influences the late portion. GABA is rapidly removed by uptake into 
both glia and presynaptic nerve terminals and then catabolized by GABA transaminase. 
Experimental and clinical study evidence indicates that GABA has an important role in the 
mechanism and treatment of epilepsy:  
 
(a) Abnormalities of GABAergic function have been observed in genetic and acquired 
animal models of epilepsy;  
(b) Reductions of GABA-mediated inhibition, activity of glutamate decarboxylase, 
binding to GABAA and benzodiazepine sites, GABA in cerebrospinal fluid and brain tissue, and 
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GABA detected during microdialysis studies have been reported in studies of human epileptic 
brain tissue;  
(c) GABA agonists suppress seizures, and GABA antagonists produce seizures;  
(d) Drugs that inhibit GABA synthesis cause seizures; and  
(e) Benzodiazepines and barbiturates work by enhancing GABA-mediated inhibition.   
Finally, drugs that increase synaptic GABA are potent anticonvulsants.  Two recently 
developed antiepileptic drugs (AEDs), vigabatrin (VGB) and tiagabine (TGB) are examples of 
such agents. However, their mechanisms of action are quite different (VGB is an irreversible 
suicide inhibitor of GABA transaminase, whereas TGB blocks GABA reuptake into neurons and 
glia) 
 Epileptic seizures are generally recognized as a consequence of excitation /inhibition 
(E/I) imbalance in involved neuronal networks.46 Restoring appropriate E/I balance by cell-
specific modulation at proper sites in the epileptic circuitry is crucial for intervention in seizures. 
The function of inhibitory neurons has attracted increasing attention due to their essential role in 
the regulation of neuronal activity and network synchronization, as well as the coordination of 
animal behaviors. (47, 48, 49)  
  
GABAA receptors, which mediate the fast synaptic inhibitory action of GABA, are also 
targets for several medications used in treating seizures, including benzodiazepines or 
barbiturates50.  Nineteen genes have been identified coding for distinct subunits, which assemble 
into a functional GABAA receptor composed of a combination of five of these subunits. This 
heterogeneity is reflected in the multitude of structurally distinct GABAA receptor subtypes 
expressed in various brain regions. 
 
GABAergic synaptic neurotransmission: 
Epileptic seizures are manifestations of synchronized waves of uncontrolled but transient 
electrical activity in populations of neurons in the brain. Neurons communicate with each other 
at specialized contact points termed synapses by releasing neurotransmitters that bind to 
receptors located on the surface of the receiving neuron. Depending on the neurotransmitter, the 
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type of receptor, and the prevailing ionic gradients, the receiving neuron is either excited or 
inhibited. In the healthy brain, a delicate balance between excitation and inhibition is maintained 
that ensures the efficient functioning of neuronal networks. Disease processes that tip the scales 
in favor of excitation result in agitation or even seizures, while excessive inhibition of large 
numbers of neurons results in sedation. Accordingly, many antiepileptic drugs act by promoting 
inhibition in the brain. 
 
2.11 OTHER TREATMENTS  
Surgery 
If treatment with medications does not work, some individuals with epilepsy may be 
candidates for brain surgery. To be eligible for the surgery the person must have seizures coming 
from one area of the brain that can be removed without causing damage to the person’s ability to 
function. If a defect in the brain (such as a scar) can be identified as the cause of the seizures and 
is confined to a small area, surgically removing that area can eliminate seizures in up to 80% of 
people, or at least reduce the severity and frequency of seizures. 
Vagus Nerve Stimulator 
The Vagus Nerve Stimulator is a device that is implanted in a person. Electrical 
stimulation of the vagus nerve can reduce the number of a certain type of seizures by more than 
one half in some people. This treatment is used when seizures continue despite use of AEDs and 
when surgery is not a possibility. 
The vagus nerve is thought to have indirect connections to areas of the brain often 
involved in causing seizures. A device that looks like a heart pacemaker is implanted under the 
left collarbone and is connected to the vagus nerve in the neck with a wire that runs under the 
skin. The device causes a small bulge under the skin. The operation to implant the device is done 
on an outpatient basis and takes about 1 to 2 hours.  When people sense that a seizure is about to 
begin, they can activate the magnet mode of their device to deliver an on-demand dose of 
stimulation. Otherwise the device is programmed to deliver intermittent stimulation to the vagus 
nerve. Vagus nerve stimulation is used in addition to AEDs. Side effects of this device include 
hoarseness, cough, and deepening of the voice when the nerve is stimulated. 
Ketogenic Diet 
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The ketogenic diet, which is very high in fats and low in carbohydrates, was first 
developed almost 80 years ago. It makes the body burn fat for energy instead of glucose. It has a 
success rate of 75%, stopping seizures in 50% of individuals and further reducing seizures in 
25% of cases. It is a strict diet, and takes a strong commitment from the whole family. The 
ketogenic diet is not a do it yourself diet. It is a serious form of treatment that, like other 
therapies for epilepsy, has some side effects that have to be monitored.  More research is being 
done to learn about the underlying reasons for the diet’s positive effect. 
 
2.12 ANIMAL MODELS IN EPILEPSY: 
 Animal models of epilepsy provide information about the pathogenesis of epileptic 
disorder and for studying the efficacy of potential therapies and their mechanism of action. 
Kainic acid model: 
Kainic acid was one of the first compounds used to model TLE in rodents45. It is an L-
glutamate analogue, the systemic or intra-cerebral administration of which causes neuronal 
depolarization and seizures, preferentially targeting the hippocampus56. 
Pilocarpine model: 
Pilocarpine is a muscarinic acetylcholine receptor agonist. Systemic or intracerebral 
injection of pilocarpine causes seizures that build up into a limbic SE47, 48.  Structural damages 
and subsequent development of spontaneous recurrent seizures resemble those of human 
complex partial seizures59. 
Kindling model: 
Kindling is the most studied model of electrical stimulation. Kindling refers to a seizure-
induced plasticity phenomenon that occurs when repeated AD induction by electrical stimulation 
in a specific brain region evokes a progressive enhancement of seizure susceptibility. Ultimately, 
it culminates in emergence of spontaneous seizures and the establishment of a permanent 
epileptic state.60 
Hyperthermic seizure:  
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Febrile seizures are frequent in early life, with a prevalence of 2%–5% in children 
younger than 5 years61 (defined as seizures longer than 15 minutes with focal onset and possible 
recurrence within 24 hours). Animal models of febrile seizure were developed to investigate 
whether febrile seizures per se induce neuronal damage leading to epileptogenesis, and which 
mechanisms generate febrile seizures62. 
Audiogenic model: 
Audiogenic seizures (AS) are generalized seizures provoked by high-intensity acoustic 
stimulation. Activation of auditory pathways is crucial for AS development, and the inferior 
colliculus in the auditory midbrain plays a key role in audiogenic seizure initiation, although 
other structures participate in AS progression63, 64. 
Strychnine (STR) induced convulsions: 
The mice were randomly divided into groups as described above. The induction of STR 
induced convulsion was carried out according to previously described method55.  Immediately 
after STR administration mice were observed for next 60 min for following symptoms: 
 
1. Onset of convulsion, duration of clonic convulsion, duration of tonic convulsion 
2. Incidence (number of mice showing convulsions); mortality 
 
Picrotoxin (PTX) induced convulsions: 
The mice were randomly divided into groups as described above. The induction of PTX 
induced convulsion was carried out according to previously described method56.  Immediately 
after PTX administration mice were observed for next 30 min for following symptoms: 
1. Onset of convulsion, duration of clonic convulsion, duration of tonic convulsion 
2. Incidence  (number of mice showing convulsions); mortality 
Pentylenetetrazole (PTZ) induced convulsions: 
The induction of PTZ induced convulsion was carried out according to previously 
described method57.  Immediately after PTZ administration mice were observed for next 30 min 
for following symptoms: 
1. Onset of convulsion, duration of clonic convulsion, duration of tonic convulsion 
2. Incidence (number of mice showing convulsions); mortality 
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Table 1: Common methods used to induce convulsion in animal models68 
Animal models Methods to induce convulsion Types of seizures 
Invivo model Electrical stimulation: 
Maximal electroshock(MES) 
Kindling 
 
Chemoconvulsants: 
Pentylenetetrazole (PTZ) 
 
Strychnine 
 
Picrotoxin 
 
Isoniazid 
 
Lithium pilocarpine 
 
Yohimbine 
 
Bicuculline 
 
4-aminopyridine 
 
N-methyl d- aspartate 
Penicillin 
 
Generalised tonic-clonic seizures 
Chronic partial seizures 
 
Myoclonic and absence seizures 
 
Acute simple partial seizures 
 
Acute simple partial seizures 
 
Clonic-tonic seizures 
 
Status epilepticus 
 
Clonic seizures 
 
Acute simple partial seizures 
 
Clonic-tonic seizures 
 
Status epilepticus 
Generalised tonic-clonic and  
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Absence Seizures 
Invitro model Hippocampal slices 
GABAA receptor binding Assay 
Complex partial seizures 
Genetic model Photosensitive baboons 
Audiogenic seizures mice 
Totterer mice and seizures -prone 
mouse 
Strains  
Genetically epilepsy- prone rats 
 
Generalised tonic- clonic seizures 
 
TABLE 2: ANTI-EPILEPTIC DRUG CLASSIFICATION 
S. 
NO. 
CLASSIFICATION DRUG NAME 
1 Hydantoins Phenytoin, mephenytoin 
2 Barbiturates Phenobarbitone, mephobarbitone 
3 Deoxybarbiturate Primidone 
4 Iminostilbene Carbamazepine 
5 Succinimide Ethosuximide 
6 GABA transaminase 
inhibitors 
Valproic acid, vigabatrin 
7 Benzodiazepines Diazepam, clonazepam, lorazepam, clorazepate 
   
 NEWER AGENST  
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8 GABA analogues Gabapentin, vigabatrin, tiagabine 
9 Others Lamotrigine, levetiracetam, felbamate, topiramate, 
zonisamide, lacosamide, rufinamide 
 
TABLE 3: DRUG PROFILE FOR ANTI-EPILEPTIC DRUGS 
S. 
NO. DRUG NAME MOA ADVERSE EFFECT USES 
1 Phenytoin 
 
Blockade of voltage 
dependent Na+ channels 
 Gingival 
hyperplasia 
 Hypersensitivity 
 Megaloblastic 
anaemia 
 Teratogenicity 
(foetal hyndatoin 
syndrome) 
 Tonic-clonic 
seizure 
 Trigeminal 
neuralgia 
 Cardiac 
arrhythmias 
2 Phenobarbitone Facilitated GABA 
mediated opening of Cl- 
ion channels 
 Sedation 
 Nystagmus 
 Megaloblastic 
anaemia 
 Osteomalacia 
 Skin rashes 
 Generalized 
tonic-clonic 
seizures 
 Partial seizure 
3 Primidone Same as phenytoin  Same as 
phenobarbitone 
 Generalized 
tonic-clonic 
seizures 
 Partial seizure 
4 Carbamazepine Blocks sodium channels  Antidiuretic effect  Trigeminal 
neuralgia 
 Glossopharyngeal 
neuralgia 
 
5 Ethosuximide Reduces low threshold 
calcium currents 
 Epigastric pain 
 Anorexia 
 Euphoria 
 Lethargy 
 Thrombocytopenia 
 Absence Seizure 
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6 Valproic acid Increase the level of 
GABA 
Blocks sodium channel 
Decrease low threshold 
Ca++ 
 Hepatotoxicity 
 Teratogenecity 
Cause Neural Tube 
Defects 
 Idiosyncratic 
Thrombocytopenia 
 Alopecia 
 Ataxia 
 Rashes 
 Partial And 
Generalized 
Seizure 
 Absence Seizure 
 Mood stabilizer 
7 Diazepam Potentiate the GABA 
action 
 Constipation 
 Blurred Vision 
 Slurred Speech 
 Hypotension 
 Hangover 
 Febrile 
convulsion 
8 Gabapentin Enhance release of GABA  Dizziness 
 Ataxia 
 Tremor 
 Rhinitis 
 
 Partial seizure 
 
9 Vigabatrin Irreversible inhibition of 
GABA transaminase 
enzyme 
 Depression   Refractory 
epilepsy 
10 Tiagabine  Depression of GABA 
transporter GAT-1 
 Nervousness 
 Amnesia  
 Asthenia  
 Sedation  
 Partial seizure  
11 Topiramate Blocks Na+ channel 
Blocks AMPA receptor 
Enhance GABAA current 
 Fatigue 
 Drowsiness 
 Dizziness 
 Formation of renal 
calculi 
 Dysguisia 
 Cognitive 
dysfunction 
 Partial, 
generalized 
seizure 
 Absence seizure 
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Table 4: Correlation between mechanisms of epileptogenesis and mechanisms of action of AEDs   
 
 Mechanisms of epileptogenesis Mechanisms of actions of AEDs 
GABA  Reduced GABA in microgyric cortex 
 Reduced benzodiazepine receptor binding 
in medial thalamic nucleus (mesial 
temporal lobe epilepsy) 
 Reduced benzodiazepine receptor density in 
CA1 region (hippocampal sclerosis) 
  Reduced GABA levels and GAD activity 
(epileptic foci) 
  Auto-antibodies to GAD (Stiff-man 
syndrome) 
 Increased functional pool of 
GABA (vigabatrin, 
tiagabine) 
 Enhanced GABA-ergic 
inhibition (benzodiazepines) 
 GABA agonistic effects 
(progabide) 
 (Weaker) GABA-ergic 
properties (phenobarbital, 
gabapentin, topiramate, 
valproate, zonisamide) 
Glutamate  Upregulation of hippocampal ionotropic 
glutamate receptors (temporal lobe 
epilepsy) 
 Anti-gluR3 antibodies (Rasmussen 
encephalitis) 
 Increased plasma glutamate levels (absence 
seizures) 
 Inhibition of glutamate 
release (lamotrigine) 
 Block of glycine site at 
NMDA receptor 
(felbamate) 
Sodium 
channel 
 Mutation voltage-gated Na+ channel 
(generalized epilepsy with febrile seizures) 
 Reduction of voltage-gated 
Na+ currents 
(carbamazepine, felbamate, 
lamotrigine, oxcarbazepine, 
phenytoin, topiramate, 
valproate, zonisamide) 
 
Potassium  
channel 
Calcium 
channel 
 
 Mutation voltage-gated K+ channel (benign 
familial neonatal convulsions) 
  
 
 Reduced ACh-mediated Ca flux _ 
(nocturnal frontal lobe epilepsy) 
 
 
 Reduction of T-type Ca++ 
currents (ethosuximide, 
valproate) 
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PLANT PROFILE 
 
DESCRIPTION 
 Plant name : Cassia alata Linn. 
 Family  : Caesalpiniaceae  
Scientific Classification  
 Kingdom : Plantae 
 Order  : Fabales 
 Family : Fabaceae 
 Subfamily : Caesalpinioideae 
 Tribe  : Cassieae 
 Subtribe : Cassiinae  
 Genus  : Senna  
 Species : S. alata 
Bionomial name  : Senna alata  
Synonyms   : Cassia alata Linn.  
Vernacular names:   
 Tamil  : Semaiagathi, Vandugolli 
English : Ringworm shrub, winged senna  
Sanskrit : Dadrughna, Dvipagsti69  
 Cassia alata Linn. is a large shrub with thick downy branches, found wild almost 
throughout India. Leaflets are 8-12 pairs, lower leaflet oblong-elliptic; upper ones broadly 
obovate70. It is also known as Ringworm shrub and winged senna in English. The leaves of the 
plant are used as purgative, expectorant astringent, vermicide and to treat all skin diseases71.  
Extracts of Cassia alata leaves have been reported to possess analgesic, anti-bacterial, anti- 
inflammatory, fungicidal, hypoglycaemic, laxative, and oxytocic and wound healing activity72. 
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Figure 8 
 
Figure 9  
(7) Cassia alata Linn. whole  plant (8) Cassia alata Linn. flower 
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It is a pan tropical, ornamental shrub. Its seeds are reported to be alternative of legumes 
due to high proteins and carbohydrates73. 
 In Ayurveda, these plants are reported to be useful in jaundice, and in other traditional 
system of medicine are highly valued for treatment of various ailments74. 
 Cassia alata Linn. leaf obtain from Neigeria having some phytochemical groups in their 
leaves and roots that has been reported to be useful in treating constipation, food poisoning, 
burns, wounds, and ringworm as well as exzema75. 
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4. LITERATURE REVIEW 
In Vitro Anthelmintic Activity of Leaf Ethanolic Extract of Cassia alata and Typha 
Angustifolia 
 The ethanolic extract of Cassia alata and Typha angustifolia have shown invitro 
Anthelmintic activity. Tannin like polyphenolic compounds produces that anthelmintic activity76. 
Antimicrobial Activity of Cassia alata and Phyllanthus amarus 
 The Cassia alata showed antimicrobial activity. Antifungal activity of aqueous extract of 
Cassia alata was found against Candida albicans   by using zone  of  inhibition method77. 
Antibacterial and antioxidative compounds from Cassia alata Linn. 
The Cassia alata showed weak antibacterial activity against Gram-positive bacteria.  
Emodin isolated from the Cassia alata, which is the main constituent possess antibacterial 
activity78. 
Antipyretic activity of aqueous and ethanolic extracts of Cassia alata Linn Leaf. 
 The aqueous and ethanolic extracts of Cassia alata possess antipyretic activity.  
Ethanolic extract having higher antipyretic activity than water extract79. 
In  vitro antimalarial activity of 11 terpenes isolated from cassia alata and ocimum 
gratissimum leaves. screening of their binding affinity with haemin  
The Cassia alata having antimalarial activities by the presence of isolated terpene as  4 
terpenes from Cassia alata. Terpenes from Cassia alata and Ocimum gratissimum are very 
active compounds in malaria treatment80. 
Effects of Cassia alata Root Extract on Smooth Muscle Activity   
The root extracts of Cassia alata showed Smooth muscle activity like oxytocin and 
prostaglandin in the enhancement of labour during maternal delivery.  Used as abortifacient and 
laxative drugs especially in life threatening situation81. 
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Antimicrobial activity of Cassia alata 
The methanolic extracts of leaves have shown antimicrobial activity and tested in bacteria 
and fungi. The of Cassia alata have very strong activity against bacteria and fungi due to 
presence alkaloidal salts and base. So the plant (flower and leaf) can be useful for the treatment 
of fungal skin diseases82. 
 Acetylcholinesterase inhibition by some promising Brazilian medicinal plant 
The plant extract showed acetylcholinesterase inhibition properties. The Cassia alata 
species possess activity similar to the galanthamine. So it can be useful for the treatment  of  
Alzheimer disease along with antioxidant activity and anti-inflammatory activity83. 
Antiviral activity of Cassia alata Linn. extracts against cardiac coxsackievirus B3 infections 
in vitro and in vivo 
The aqueous extract of Cassia alata showed potential antiviral agent for the treatment of 
myocarditis. And the aqueous extract significantly reduced the morbidity, mortality, virus titers, 
necrosis and mononuclear cell infiltration of heart tissues. Also the extract shows the ability to 
maintain levels of LDH, AST, and CK enzymes at normal level in the treated infected mice 
compared with those untreated infected mice84. 
Weight-lowering effects of Cassia alata, Cassia fistula and Caesalpinia pulcherrima leaf 
extracts 
 The Cassia alata and Cassia fistula can significantly and effectively reduced the body 
weight and weight of parametrial fat in mice possibly due to their tannin contents which inhibit 
the activity of lipases thereby lowering their body fat content85. 
Antibacterial activity of leaf extract of Cassia alata separated by soxhlet extraction method 
  The leaves of Cassia alata showed antibacterial activity against the bacterial strains 
Pseudomonas aeruginosa which was compared with standard drugs86. 
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Antioxidant and Anti-Inflammatory Activities of Extracts from Cassia alata, Eleusine 
indica, Eremomas taxspeciosa, Carica papaya and Polyscias fulva Medicinal Plants Collected 
in Cameroon 
 The Cassia alata having Antioxidant and Anti-Inflammatory activities. The extracts from 
leaves of Cassia alata have better antioxidant activities than Carica papaya or Eleusine Indica. 
The presence of Chrysarobin, tannin, Kaempferol, Isochrysophanol, Chrysophanol glycoside 
Chrysarobin explained Antioxidant and Anti-Inflammatory87. 
Inhibitors of platelet aggregations 
 The isolated adenine from Cassia alata Linn. posses strong inhibitory effects on platelet 
aggregation induced by collagen. Here the adenine was isolated by HPLC using a tryacontylsilyl 
silica (C13)88. 
Invitro antifungal activity of Cassia alata Linn. flower extract    
The aqueous extract of Cassia alata showed inhibition of growth of aflatoxin produced 
from plant and human pathogenic fungi89. 
Effect of Cassia  alata (L) Roxb (Fabaceae) Leaf Extracts on alpha-Amylase, alpha- 
Glucosidase and Postprandial Hyperglycemia in Rats 
The acetone and hexane extracts of Cassia alata showed anti-diabetic activity by 
inhibition of α- amylase and α-glucosidase.  The mode of inhibiting both enzymes is competitive 
and uncompetitive inhibition, respectively.  The hexane extract also reduces sucrose-induced 
postprandial hyperglycaemia in rats. So Cassia alata leaf extracts can inhibit α-amylase as well 
as α- glucosidase and reduced postprandial hyperglycaemia in diabetes induced rats.90 
Anti-inflammatory Activity of Heat-treated Cassia alata Leaf Extract and Its Flavonoid 
Glycoside 
 Cassia alata leaves showed various anti-inflammatory activities.  The inhibitory effects 
on the histamine release induced by Concanavalin A were notable in the extracts of heat-
treated81. 
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5. SCOPE AND PLAN OF WORK 
Scope: 
 According to the WHO, there are over 50 million suffers in the world today of which 80% live 
in the developing countries. An estimated 3.2 million new cases occur each year globally, with atleast 
55% of the cases begin in childhood. Epilepsy responds to treatment about 75% of the time, some 
cases show poor treatment due to inadequate medical supply and proper treatment. Epilepsy increases 
a person’s risk of premature death by about two to three times. It is the most common serious brain 
disorder worldwide with no boundaries. 
 Management of epilepsy is a global problem and successful treatment is very essential for 
preventing or at least delaying the onset of long-term complications. Remedies to treat such different 
types of seizure are available in nature in the form of herbal medicines or drugs with very minimal 
adverse effects when compared to the available synthetic drugs. Such herbal drugs as therapeutic 
agents are a boon when compared to the severe adverse effects of the allopathic medical practice for 
epileptic seizure, though the quest for a complete and permanent cure for the disease is being pursued 
relentlessly by eluding physicians and researchers. 
 Therefore herbal medicines have been used for the treatment of various disease because of 
their fewer adverse effects that conventional medicine.  It is believed that the traditional medicines 
used for the treatment of epilepsy and also in progression of complications of the disease. 
 Main objective of the proposed work is to evaluate the beneficial effects of Cassia alata Linn. 
for its anti-epileptic activity by using MES and INH model. 
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PLAN OF WORK 
6. PLAN OF WORK 
1. Collection and Authentification of Cassia alata Linn. 
2. Preparation of ethanolic extract of Cassia alata Linn. (EECA) 
3. Experimental Animals 
4. Preliminary Phytochemical screening  
5. Acute toxicity studies (OECD 423guidelines) 
6. Effect of EECA on MES induced epilepsy 
7. Effect of EECA on INH induced epilepsy 
8. Effect of EECA on GABA level in animal 
9. Histopathology 
10. Statistical analysis by one way ANOVA followed by Dunnet’s test 
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MATERIALS AND METHOD: 
6.1 Collection and Authentification: 
           The leaves of Cassia alata Linn. were collected from local source, Tamil Nadu in March. 
The plant material was identified and authenticated by Dr. D. Aravind, M.D. (S), M.Sc., 
Assistant Professor, Department of Medicinal Botany, National Institute of Siddha, Chennai–
600047, Tamilnadu. Certificate number NISMB2132016. A voucher specimen was submitted at 
C.L. Baid Metha College of Pharmacy, Chennai- 600097 
6.2 Preparation of ethanolic extract of Cassia alata Linn. (EECA) 
The leaves of Cassia alata Linn. was collected and ground into coarse powder. The 
powdered leaves were extracted with ethanol  in Soxhlet’s apparatus. 
6.2.1 Method of Extraction: 
The powdered leaves were extracted with ethanolic solvent at room temperature for 24 
hours using soxhlet’s apparatus. The extract process was repeated twice. The combined filtrates 
were then evaporated under reduced pressure to give a viscous mass, which gave a greenish 
golden coloured residue. The extract was stored at 0-4°C. 
6.2.2. Percentage yield: 
The percentage yield of hydro alcoholic extract was 2.77% w/w and it was preserved in 
refrigeration for further use.         
6.3. Experimental Animals: 
 Swiss albino mice of weighing 25-30gm were used for this study. The inbred animals 
were procured from the animal house of C.L. Baid Metha College of Pharmacy, Thorapakkam, 
Chennai- 97. They were housed five per cage under standard laboratory conditions at a room 
temperature at 22±20 C with 12 hr light/dark cycle. The animals were acclimatized to laboratory 
conditions for one week provided with standard pellet chow and water ad libitum. Ethical 
committee approval was obtained from IAEC of CPCSEA. (IAEC/XLVII/01/CLBMCP/2015 
dated: 20/11/2015) 
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6.4 Phytochemical analysis: 92 
           The Cassia alata Linn. was subjected to preliminary phytochemical screening for the 
presence or absence of phytoconstituents by the following methods.    
I. Test for alkaloid:  
The extract was treated with dilute hydrochloric acid and filtered. The filtrate was used in the 
following tests. 
a) Mayer’s reagent (Potassium Mercuric Iodine Solution)  
0.5ml of the extract was treated with Mayer’s reagent and the appearance of cream color 
indicates the presence of alkaloid 
b) Dragendroff’s test (Potassium Bismuth Iodide)  
0.5ml of the extract was treated with Dragendroff’s reagent and the appearance of reddish brown 
color precipitate indicates the presence of alkaloid.  
c) Hager’s test (Saturated solution of Picric acid)  
0.5ml of the extract was treated with Hager’s test and the appearance of yellow color precipitate 
indicates the presence of alkaloid.  
d) Wagner’s test (Iodine-Potassium Iodide Solution)  
0.5ml of the extract was treated with Wagner’s test and the appearance of brown color precipitate 
indicates the presence of alkaloid.   
II. Test for Carbohydrates   
a) Molisch’s test:  
The extract was treated with 3ml of alpha-napthol in alcohol and concentrated sulphuric acid was 
added along the sides of the test tube carefully. Formation of violet color ring at the junction of 
two liquids indicates the presence of carbohydrates.      
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b) Fehling’s test (CuSO4.7H2O+KOH+Potassium Tartartes): 
The extract was treated with Fehling’s solution A and B heated in boiling water for few minutes. 
The appearance of reddish brown color precipitate indicates the presence of reducing sugars.  
c) Benedict’s test (Sodium citrate + sodium carbonate + CuSO4.7H2O) 
The extract was treated with Benedict’s test and heated in boiling water for few minutes. The 
appearance of reddish orange color precipitate indicates the presence of reducing sugars.  
d) Barfoed’s test (Copper Acetate+ Glacial acetic acid) 
The extract was treated with Barfoed’s test and heated in boiling water for few minutes. The 
appearance of reddish orange color precipitate indicates the presence of non- reducing sugars.   
III. Test for steroids  
a) Liberamannburchard test:  
The extract was treated with small quantity of concentrated sulphuric acid, glacial acetic acid and 
acetic anhydride. The appearance of green color indicates the presence of steroids   
IV. Test for proteins  
a) Biuret’s test: 
The extract was treated with copper sulphate and sodium hydroxide solution. The appearance of 
violet color indicates the presence of proteins.  
b) Millon’s test: 
The extract was treated with Millon’s reagent. The appearance of pink color indicates the 
presence of proteins.  
V. Test for Tannin’s  
a) The extract was treated with 10% lead acetate solution. The appearance of white precipitate 
indicates the presence of tannins.  
b) The extract was treated with aqueous bromine solution. The appearance of white precipitate 
indicates the presence of tannins.   
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VI. Test for Phenols  
a) The extract was treated with neutral ferric chloride solution. The appearance of violet 
indicates the presence of phenols.  
b) The extract was treated with 10% sodium chloride solution. The appearance of cream color 
indicates the presence of phenols.  
VII. Test for Flavonoid 
a) 5ml of extract solution was hydrolysed with 10%v/v sulphuric acid and cooled. Then, it is 
extracted with diethyl ether and divided into three portions in three separate test tubes. 1ml of 
diluted sodium carbonate, 1ml of 0.1N sodium hydroxide, and 1ml of strong ammonia solution 
were added to the first, second and third test tubes respectively. In each test tube, development of 
yellow color demonstrated the presence of flavonoids.  
b) Shinoda’s test: The extracts were dissolved in alcohol, to that one piece of magnesium is 
added followed by concentrated hydrochloric acid along the sides of the test tube drop wise. It is 
heated in a boiling water bath for few minutes. The appearance of magenta colour indicates the 
presence of flavonoids.  
VIII. Test for Gums and Mucilage 
The extract was treated with 25ml of absolute alcohol and then solution was filtered. The filtrate 
was examined for its swelling properties.       
IX. Test for Glycosides 
The extract was dissolved in the glacial acetic acid and few drops of ferric chloride solution was 
added, followed by the addition of concentrated sulphuric acid, formation of red ring at the 
yjunction of two liquids indicates the presence of glycosides.   
X. Test for Saponins 
1ml of the extract was diluted to 20ml with distilled water and shaken well in a test tube. The 
formation of foam in the upper part of the test tube indicates the presence of saponins.   
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XI. Test for Terpenes 
The extract was treated with tin and thionyl chloride, appearance of pink color indicates the 
presence of terpenes.   
XII. Test for sterols 
The extract was treated with 5% potassium hydroxide solution; appearance of pink color 
indicates the presence of sterols.   
 
6.5. Acute toxicity studies93 
 The procedure was followed by using OECD guidelines (Organization for Economic Co-
Co-operation and Development) 423(acute toxic class method).  The acute toxicity study is a 
step wise procedure with 3 animals of single sex per step. Depending on the mortality and/or 
morbidity status of the animals, on the average 2-4 steps may be necessary to allow judgment on 
the acute toxicity of the substances. This procedure results in the use of a specified number of 
animals while allowing for acceptable data-based scientific conclusion. The method used defined 
doses (2000mg/kg body weight) and results allow a substance to be ranked and classified 
according to the globally harmonized system (GHS) for classification of chemical which cause 
acute toxicity.   
Procedure:  
 Swiss albino mice weighed 25-30gms were used for the study. The starting dose level of 
EECA was 2000mg/kg body weight p.o Most of the crude extracts possess LD50 value more than 
2000 mg/kg, p.o so starting dose used was 2000mg/g p.o Food was withheld for a further 3-4 
hrs.After administration (p.o) of drugs and observed for the signs of toxicity.    
 Body weights of mice before and after administration were observed for morbidity and 
mortality. Any changes in skin, fur, eyes, mucous membrane, respiratory, circulatory, autonomic 
& central nervous system, motor activity and behaviour pattern were observed and also sign of 
tremors, convulsion, salivation, diarrhoea, lethargy, sleep and coma were noted.  
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Figure 10: Flowchart of acute toxicity studies 
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Experimental Design 
Anti-epileptic activity 
Method- I 
6.6. Maximal electroshock seizures (MES) Convulsions94, 95 
Procedure: 
The animals were divided into 5 groups each constituting 6 mice. Group I were normal mice, 
Group II were negative control. Group III animals were treated with phenytoin 25mg/kg b.w/p.o. 
Group IV were treated with EECA 200mg/kg b.w/ p.o. and Group V were treated with EECA 
400mg/kg b w/p.o. for 14 days. 
MES model is one of the physical method to evaluate the anti-epileptic activity of drug.  
Seizures were induced to group II, III, IV and V by using an Electoconvulsiometer. Maximal 
electroshock seizures were elicited by a 60 HZ alternating current of 50mA intensity for 0.2 sec96 
was applied to the animal using corneal electrode. On 14th day extracts were administered before 
the induction of seizures. The various stages of epilepsy like Flexion, Extensor, Clonus, Stupor 
and Recovery were observed. The percentage protection was estimated. 
Group I- Normal control 
Group II – Negative control MES 60 Hz alternating current of 45mA intensity for 0.2 sec 
Group III- Phenytoin 25mg/kg p.o. + MES 60 Hz alternating current of 45mA intensity for 0.2 
sec 
Group IV-EECA 200mg/kg p.o + MES 60 Hz alternating current of 45mA intensity for 0.2 sec 
Group V- EECA 400mg/kg p.o + MES 60 Hz alternating current of 45mA intensity for 0.2 sec 
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Method- II 
6.7. Isoniazid (INH) induced seizures97, 98 
The animals were divided into 5 groups each constituting 6 mice. Group I were normal mice, 
Group II were negative control. Group III animals were treated with phenytoin 25mg/kg b.w/p.o. 
Group IV were treated with EECA 200mg/kg b.w/ p.o. and Group V were treated with EECA 
400mg/kg b w/p.o. for 14 days. 
INH model is one of the chemically induced method to evaluate anti-epileptic activity of the 
drug.  On 14th day extracts were administered before the induction of seizures.  Seizure is 
induced to groups II, III, IV and V by using intraperitoneal administration of 300 mg /kg of 
Isoniazid in mice.  Status of animal live after 30min, 24 hrs and Percentage  protection were 
calculated. 
 
Group I   - Normal control 
Group II - Negative control Isoniazid 300mg/kg i.p. 
Group III - Standard phenytoin 25mg/kg + Isoniazid 300mg/kg i.p 
Group IV - Low dose 200mg/kg p.o + Isoniazid 300mg/kg i.p. 
Group V - High dose 400mg/kg p.o + Isoniazid 300mg/kg i.p. 
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6.8. Determination of the effect of EECA and standard on neurotransmitter concentration 
in mice brain after induction of epilepsy 
Estimation of GABA level in mice brain:  
Preparation of standard solutions 
 1 N HCl was prepared in 80% ethanol which was used to dissolve GABA (γ-amino 
butyric acid) and glutamate 
Preparation of stock solution 
 Stock solutions of GABA and glutamate were prepared by dissolving 10 mg of the 
respective amino acid in 10 ml of 0.1 N HCl in 80% ethanol. From this stock solution, working 
standard solutions of concentration 10ng, 20ng, 40ng, 80ng, 120ng, 160ng, 200ng in 5µl for 
GABA were prepared in 10 ml volumetric flasks and adjusting the volume with 0.1 N HCl in 
80% ethanol.  
Preparation of 0.2% ninhydrin solution 
 200 mg of ninhydrin was dissolved in a small amount of acetone in a 100 ml standard 
flask. To this, 1 ml of pyridine was added and the volume was made up to 100 ml with acetone 
Chromatographic condition 
Stationary phase  : Silica gel GF254;  
Mobile phase  : n-butanol: glacial acetic acid: water (65:15:25 v/v/v);  
Saturation time  : 3 hr;  
Instrument : HPTLC (Camag–version 1.3.4);  
Applicator : Linomat V;  
Scanner : Camag TLC scanner III;  
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Developing chamber : Twin trough glass chamber (20×10);  
Developing mode : Ascending mode (multiple development);  
Detection reagent : 0.2% ninhydrin in acetone;  
Scanning wavelength : 486 nm; 
Experimental condition : 25oC; Temp/RH: 55–65%. 
Calibration curve 
 Ten µl of different concentration of standard 5µl of GABA and glutamate standard 
solution were applied in triplicate on a pre-coated HPTLC plate. Spots were dried in a hot air 
oven at 60–650C for 1–2 min and the plate was developed in the mobile phase n-butanol: glacial 
acetic acid: water (65:15:25 v/v/v). When the solvent front reached about 8.0 cm (marked 
previously), the plates were removed and dried at  
60–650C for 3–4 min in a hot air oven. A second run was performed in a similar way. The plates 
were then dipped  in 0.2% ninhydrin reagent for 1 sec and dried in a hot air oven at 60–650C for 
3–4 min. The spots were scanned at 486 nm and the peak areas were recorded. Calibration curves 
of GABA and glutamate were prepared by plotting areas v/s concentration. 
Calculation 
 Brain samples were homogenized each 10mg in 200µl of solvent. Hence 1 mg tissue 
needs 20µl volume. 
 Final results were expressed of ng of protein per mg of tissue. 
 Total 10µl of sample volume were taken to measure neurotransmitter quantity. These 
samples gave peak area as a measure of concentration that was interpolated from standard 
plot with the help linear regression statistics of graph pad prism 4.01. 
 To express the neurotransmitter quantity in ng/mg tissue, final interpolated 
concentrations from standard plot were multiplied by 2. 
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6.9 METHODS FOR HISTOPATHOLOGICAL STUDY99 
The mice from each group were anaesthetized using inhalation of chloroform. The brain 
was carefully removed without any injury after opening the skull. The collected brain was 
washed with ice cold normal saline and fixed in 10% formalin saline. 
Paraffin embedded sections were taken 100μm thickness and processed in alcohol-xylene 
series and stained with Haematoxyli-Eosin dye. The sections were examined microscopically for 
histopathological changes in the cortex zone. 
6.10  STATISTICAL ANALYSIS 
The statistical analysis was carried by one way ANOVA followed by Dunnet’s ―t test. P 
values <0.05 (95% confidence limit) was considerd statistically significant, using Software 
Graph pad Prism 6.01 
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7. RESULTS 
7.1 Preliminary Phytochemical analysis of Ethanolic extract of Cassia alata Linn. (EECA) 
The result of preliminary phytochemical analysis of Ethanolic extract of Cassia alata 
Linn. showed presence of various phytochemical constituents such as Carbohydrates, phenols, 
Flavonoids, steroids, alkaloids, glycoside and saponins with absence of terpenes, sterol, protein, 
tannins, gums and mucilage. (Table 6) 
7.2 Acute Oral Toxicity Study: 
The Acute Oral Toxicity Study was done according to the OECD guidelines 423 (Acute 
toxic class method). A single administration of 2000 mg/kg b.w /p.o of EECA was administrated 
to three adult female Swiss albino mice and observed for 7 days. There was no considerable 
change in body weight before and after treatment and no sign of toxicity was observed. (Table 7) 
7.3 Effect of EECA on MES induced epilepsy model: 
Effect of EECA on Flexion in MES induced epilepsy model: 
  Flexion in MES induced epilepsy model, group I was significantly decreased when 
compared with group II, III, IV and V (p<0.001).  
Group II was significantly increased when compared with group III, IV and V (p<0.001). 
Group III was significantly increased when compared with Group IV and V (p<0.001). 
(Table 8, Figure 11)      
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Effect of EECA on Extensor in MES induced epilepsy model: 
 Extensor in MES induced epilepsy model, group I was significantly decreased when 
compared with Group II, III, IV and V (p<0.001).   
Group II was significantly increased when compared with group III and IV (p<0.001). 
Group II was significantly decreased when compared with group V (p<0.001).   
Group III was significantly decreased when compared with group IV and V (p<0.001). 
(Table 8, Figure 12)   
Effect of EECA on Clonus in MES induced epilepsy model: 
Clonus in MES induced epilepsy model, group I was significantly decreased when 
compared with group II, III, IV and V (p<0.001).   
Group II was significantly increased when compared with group III, IV and V (p<0.001).   
Group III was significantly decreased when compared with group IV and V (p<0.001). 
(Table 8, Figure 13) 
Effect of EECA on Stuper in MES induced epilepsy model: 
Stuper in MES induced epilepsy model, group I was significantly decreased when 
compared with group II, III, IV and V (p<0.001).   
Group II was significantly increased when compared with Group III, IV and V (p<0.001).   
Group III were significantly decreased when compared with group IV (p<0.001). 
Group III was significantly increased when compared with group V (p<0.001). (Table 8, 
Figure 14) 
Effect of EECA on Recovery in MES induced epilepsy model: 
Recovery in MES induced epilepsy model, group I was significantly increased when 
compared with Group II, III, IV and V (p<0.001).   
Group II was significantly increased when compared with Group III, IV and V (p<0.001).    
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Group III was significantly decreased when compared with Group IV (p<0.001). 
Group III was significantly increased when compared with Group V (p<0.001) (Table 8, 
Figure 15)  
Effect of EECA on GABA level in MES induced epilepsy model: 
GABA levels in MES induced epilepsy model, group I was significantly increased when 
compared with Group II, III, IV and V (p<0.001).  
Group II was significantly decreased when compared with Group III, IV and V 
(p<0.001). 
Group III was significantly increased when compared with Group IV and V (p<0.001). 
(Table 9, Figure 17) 
7.4 Effect of EECA on INH induced epilepsy model: 
Effect of EECA on Latency in INH induced epilepsy model:  
Group I was significantly increased when compared with Group II, III, IV and V 
(p<0.001).  
Group II was significantly increased compared with group III, IV and V (p<0.001). 
Group III was significantly increased compared with group IV and V (p<0.001). (Table 
10, Figure 18) 
Status of animal live in INH model at 30 min interval: 
Status of animal live in INH model at 30 min interval, group I was significantly 
decreased when compared with Group II, III, IV and V.   
Group II was significantly decreased when compared with group III, IV and V.   
Group III was significantly increased when compared with Group IV and V were. (Table 
10, Figure 19) 
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Status of animal live in INH model at 24hrs interval:  
Status of animal live in INH model at 24hrs interval, group I was significantly decreased 
when compared with group II, III, IV and V.   
Group II was significantly decreased when compared with group III, IV and V.  
Group III was significantly decreased when compared with group IV and V. (Table 10, 
Figure 20) 
 
Percentage protection in INH model:  
Percentage protection in INH model, group I was significantly decreased when compared 
with group II, III, IV and V.   
Group II was significantly decreased when compared with group III, IV and V.   
Group III was significantly increased when compared with group IV and V. (Table 10, 
Figure 21) 
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Histopathology:  (Figure 22) 
Table: 5 HISTOPATHOLOGICAL ANALYSIS OF MICE BRAIN 
 
GROUP REPORT 
CONTROL 
Haematoxylin and Eosin stained section shows the 
normal brain tissue depicted intact cell architecture 
with normal amount of neurotransmiters.  
MES (60 Hz alternating current of 
45mA intensity for 0.2 sec) 
Haematoxylin and Eosin stained section shows there 
is less neuron density. 
Phenytoin (25mg/kg/p.o) +  MES (60 
Hz alternating current of 45mA 
intensity for 0.2 sec) 
Haematoxylin and eosin stained section of the brain 
tissue showed no significant alterations observed in 
this group and tissues showed a normal picture or 
brain cells, less proliferation and  more neuronal 
density at hippocampal region 
EECA (200mg/kg/p.o) + MES (60 Hz 
alternating current of 45mA 
intensity for 0.2 sec)  
Haematoxylin and Eosin stained section of the brain 
tissue showed no pathological damages and cellular 
architecture are intact with more neuronal density 
compared to the MES alone treated group.  
EECA (400mg/kg/p.o)+ MES (60 Hz 
alternating current of 45mA 
intensity for 0.2 sec) 
Haematoxylin and Eosin stained section of the brain 
tissue showed increased neuron density when 
compared to the EECA (200mg/kg/p.o) 
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FIGURES AND TABLES 
 7.1 Preliminary Phytochemical analysis of hydro alcoholic extract of leaves of Cassia alata 
Linn. 
Table: 6 
S. No. Phytochemical Presence or absence 
1 Alkaloids + 
2 Carbohydrates + 
3 Steroids + 
4 Proteins - 
5 Tannins - 
6 Phenol + 
7 Flavonoids + 
8 Gums and mucilage - 
9 Glycoside + 
10 Saponins + 
11 Terpene  - 
12   Sterols - 
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Table: 7 Acute oral toxicity studies of EECA (OECD 423 guideline) 
 
S. 
No. 
 
Treatment 
group 
 
Dose 
Weight of 
animal in gm Signs of 
toxicity 
Onset of 
toxicity 
Reversible 
or irreversible Duration Before 
test 
After 
test 
1. EECA 2g/kg    25 28 No signs 
of toxicity 
Nil Nil 14 days 
2. EECA 2g/kg 25 25 No signs 
of toxicity 
Nil Nil 14 days 
 
3. 
EECA 2g/kg 30 32 No signs 
of toxicity 
Nil Nil 14 days 
 
 
  
Evaluation of Anti-Epileptic Activity of Ethanolic Extract of Leaves of Cassia alata Linn. By 
Maximal Elecroshock (MES) and Isoniazid induced convulsions on mice 
 
Department of Pharmacology Page 61 
 
TABLE: 8 EFFECT OF EECA ON MES INDUCED CONVULSIONS 
GROUP % OF 
PROTECT
ION 
FLEXION 
(SEC) 
EXTENSOR 
(SEC) 
CLONUS 
(SEC) 
STUPOR 
(SEC) 
RECO
VERY 
(SEC) 
GROUP I NIL 0 0 0 0 0 
GROUP II 0% 3.167 ±4.401a*** 12.00±0.577a*** 17.33± 0.88a*** 25.00± 2.477a*** 127± 4.102a*
** 
GROUP III 100% 
 
2.833±0.307 
a***b*** 
10.50±0.428a
***b*** 
9±2.309a***b
*** 
20.833±1.0
14a***b*** 
122±3.
130a***
b*** 
GROUP IV 66.6% 
 
2.500±0.428a
***b***c*** 
11.33±0.822a
***b*** c*** 
12.67±1.76a*
**b*** c*** 
23.16±1.51
5a***b*** 
c*** 
126±2.
017a***
b*** 
c*** 
GROUP V 83% 1.833±0.307a
***b***c*** 
13.0±0.7303a
***b*** c*** 
11.33±0.803a
***b*** c*** 
19.66±0.91
9a***b*** 
c*** 
117.00±2.633a
***b**
* c*** 
 
Values are expressed as mean ± SEM of 6 animals. 
Comparisons were made between the following: 
a - Group I vs. II, III, IV and V, b - Group II vs. III, IV and V, c- Group III vs. IV and V. 
Statistical Significance test for comparison was done by one way ANOVA followed by 
Dunnets‘t’ test. Where *p< 0.05, **p< 0.01, ***P<0.001, ns-non significant. 
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Figure 15: 
R E C O V E R Y
G R O U P S
T
IM
E
 I
N
 S
E
C
O
N
D
S
G
R
O
U
P
 I
G
O
R
U
P
 I
I
G
R
O
U
P
 I
I I
G
R
O
U
P
 I
V
G
R
O
U
P
 V
0
5 0
1 0 0
1 5 0
G R O U P  I
G O R U P  II
G R O U P  III
G R O U P  IV
G R O U P  V
 
Figure 16: 
P E R C E N T A G E  P R O T E C T IO N
G R O U P S
P
E
R
C
E
N
T
A
G
E
 P
R
O
T
E
C
T
IO
N
G
O
R
U
P
 I
G
O
R
U
P
 II
G
O
R
U
P
 II
G
R
O
U
P
 IV
G
O
R
U
P
 V
0
5 0
1 0 0
1 5 0
 
Evaluation of Anti-Epileptic Activity of Ethanolic Extract of Leaves of Cassia alata Linn. By 
Maximal Elecroshock (MES) and Isoniazid induced convulsions on mice 
 
Department of Pharmacology Page 65 
 
TABLE: 9 EFFECT OF EECA ON LEVELS OF GABA IN MES INDUCED 
CONVULSIONS 
GROUPS TREATMENT 
GABA 
(ng/mg tissue) 
GROUP I Control  328.3±1.06 
GROUP II 
MES (60 Hz alternating current of 
45mA intensity for 0.2 sec) 
231.5±2.67*** 
GROUP III PHENYTOIN 25mg/kg  p.o. + MES 312.9±1.55*** 
GROUP IV EECA 100mg/kg  p.o. + MES 285.7±3.23*** 
GROUP V EECA 200mg/kg  p.o. + MES 293.1±3.17*** 
 
Values are expressed as mean ± SEM of 6 animals. 
Comparisons were made between the following: 
a - Group I vs. II, III, IV and V, b - Group II vs. III, IV and V, c- Group III vs. IV and V. 
Statistical Significance test for comparison was done by one way ANOVA followed by 
Dunnets‘t’ test. Where *p< 0.05, **p< 0.01, ***P<0.001, ns-non significant. 
 
 
 
 
 
 
 
 
 
 
Evaluation of Anti-Epileptic Activity of Ethanolic Extract of Leaves of Cassia alata Linn. By 
Maximal Elecroshock (MES) and Isoniazid induced convulsions on mice 
 
Department of Pharmacology Page 66 
 
Figure 17: 
G A B A  E S T IM A T IO N
G R O U P S
n
g
/m
g
G
O
R
U
P
 I
G
O
R
U
P
 II
G
O
R
U
P
 II
I
G
R
O
U
P
 IV
G
R
O
U
P
 V
0
1 0 0
2 0 0
3 0 0
4 0 0
G O R U P  I
G O R U P  II
G O R U P  III
G R O U P  IV
G R O U P  V
 
TABLE: 10 EFFECT OF EECA ON ISONIAZID INDUCED CONVULSIONS 
Values are expressed as mean ± SEM of 6 animals. 
Comparisons were made between the following: 
a - Group I vs. II, III, IV and V, b - Group II vs. III, IV and V, c- Group III vs. IV and V. 
Statistical Significance test for comparison was done by one way ANOVA followed by 
Dunnets‘t’ test. Where *p< 0.05, **p< 0.01, ***P<0.001, ns-non significant. 
GROUPS 
Latency 
(onset of 
epileptic 
seizure in 
sec) 
Status of  animal after 30min (no. of 
animals alive) 
Status of 
animal after 
24 hr (no. of 
animals 
alive) 
Percentage 
protection (in 
%) 
GROUP I 0 0 0 NIL 
GROUP II 85±3.12 
a*** 
1 0 0 
GROUP III Nil 3 3 100 
GROUP IV 128±2.43 
b***c*** 2 1 69 
GROUP V 137±1.28 
a***c*** 
3 2 83 
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Figures 22: HISTOPATHOLOGY OF HIPPOCAMPAL REGION OF BRAIN  
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8. DISCUSSION 
 Epilepsy is an assortment of different types of seizures originating from several 
mechanisms that have in common the sudden excessive discharge of cerebral neurons.  It may 
result in a. Loss of consciousness, b. Atypical or odd behaviour, c. distorted perceptions. 
 Seizures can last from a few seconds to a few minutes100. Patients and health care 
professionals do not always  recognize the signs or symptoms, which can include convulsions, a 
loss of consciousness, blank staring, lip smacking, or jerking movements of the arms and legs101. 
A seizure has a clear beginning, middle, and end. 
 Epilepsy was one of the first brain disorders to be Described102. Epileptic seizures are 
manifested by an abnormal, excessive, and hyper synchronous electrical discharge of neurons in 
the brain103.  Each distinct form of epilepsy has its own natural history and response to 
treatment101. This diversity probably reflects the many different underlying causes of epilepsy 
and the variety of epilepsy syndromes in which the clinical and pathological characteristics are 
distinctive and suggest a specific under lying etiologic mechanism104. 
The International League against Epilepsy (ILAE) published a modified version of the 
International Classification of Epileptic Seizures (ICES), which has continued to be a very 
useful system104. This system is based on the clinical features of seizures and associated EEG 
findings. The etiology or cellular substrate is not considered. There are three main types of 
seizures: partial, generalized, and unclassified.  
There are many kinds of seizures, each with characteristic behavioral changes and 
electrophysiological disturbances that can usually be detected in scalp electroencephalographic 
recordings103. A seizure is a transient epileptic event, indicating a disturbance in brain 
function101. Having a single seizure does not necessarily mean that a person has epilepsy103, 104. 
Ten percent of adul ts experience a seizure sometime during their lifetime105. 
Globally, an estimated 2.4 million people are diagnosed with epilepsy each year. In high-
income countries, annual new cases are between 30 and 50 per 100000 people in the general 
population. In low and middle-income countries, this figure can be up to two times higher. In 
many parts of the world, people with epilepsy and their families suffer from stigma and 
discrimination.102 
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Epileptic seizures arise from an excessively synchronous and sustained discharge of a 
group of neurons. The single feature of all epileptic syndromes is a persistent increase of 
neuronal excitability. Abnormal cellular discharges may be associated with a variety of causative 
factors such as trauma, oxygen deprivation, tumors, infection, and metabolic derangements. 
However, no specific causative factors are found in about half of the patients suffering from 
epilepsy. Underlying causes and pathophysiological mechanisms are (partially) understood for 
some forms of epilepsy, e.g. epilepsies caused by disorders of neuronal migration and monogenic 
epilepsies. For several other types of epilepsy, current knowledge is only fragmentary.  
Both neurotransmitter systems and ion channels play a crucial role in neuronal 
excitability106. 
The major developmental disorders giving rise to epilepsy are disorders of neuronal 
migration that may have genetic or intrauterine causes107. Abnormal patterns of neuronal 
migration lead to various forms of agyria or pachygyria whereas lesser degrees of failure of 
neuronal migration induce neuronal heterotopia in the subcortical white matter. Recent 
experimental data suggest that cortical malformations can both form epileptogenic foci and alter 
brain development in a manner that diffuse hyperexcitability of the cortical network occurs108. 
Other studies revealed increases in postsynaptic glutamate receptors and decreases in g-
aminobutyric acid receptors in microgyric cortex which could promote epileptogenesis109. 
The GABA hypothesis of epilepsy implies that a reduction of GABA-ergic inhibition 
results in epilepsy whereas an enhancement of GABA-ergic inhibition results in an anti-epileptic 
effect 110. Inhibitory postsynaptic potentials (IPSPs) gradually decrease in amplitude during 
repetitive activation of cortical circuits. This phenomenon might be caused by decreases in 
GABA release from terminals, desensitization of GABA receptors that are coupled to increases 
in Cl- conductance or alterations in the ionic gradient because of intracellular accumulation of Cl- 
111In case of intracellular accumulation of Cl-, passive redistribution is ineffective. 
Moreover, Cl—K+ co-transport becomes less effective during seizures as it depends on 
the K+ gradient. As Cl—K+ co-transport depends on metabolic processes, its effectiveness may 
be affected by hypoxia or ischemia as well. These mechanisms may play a critical role in 
ictogenesis and interictal- ictal transition.  Several studies have shown that GABA is involved in 
pathophysiology of epilepsy in both animal models and patients suffering from epilepsy. 
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GABA levels and glutamic acid decarboxylase (GAD) activity were shown to be reduced 
in epileptic foci surgically excised from patients with intractable epilepsy and in CSF of patients 
with certain types of epilepsy112. In stiff-man syndrome, a disease associated with epilepsy and 
diabetes mellitus, auto-antibodies to GAD were demonstrated113. A reduction of 3H-GABA 
binding has been reported in human brain tissue from epileptic patients whereas PET studies 
demonstrated reduced benzodiazepine receptor binding in human epileptic foci114. The degree of 
benzodiazepine receptor reduction showed a positive correlation with seizure frequency. 
The GABA receptor complex is involved in various animal models of epilepsy as well. 
Low CSF levels of GABA were revealed in dogs with epilepsy115. Reduced GAD levels were 
revealed in the substantia nigra of amygdala-kindled rats116.  Significant alterations in GABA 
and benzodiazepine binding have been shown in the substantia nigra of genetically seizure-prone 
gerbils117. Mice with a genetic susceptibility to audiogenic seizures have a lower number of 
GABA receptors than animals of the same strain that are not seizure prone118. Several 
endogenous (guanidino compounds) and exogenous (e.g. bicuculline, picrotoxin, penicillin, 
pilocarpine, pentylenetetrazol) convulsants inhibit GABAergic transmission through inhibition 
of GABA synthesis or through interaction with distinct sites at the postsynaptic GABAA 
receptor110, 119, 120.  
Convulsant agents that block synaptic GABA-mediated inhibition, amplify the dendritic 
spike-generating mechanism that involves Ca2+   (121,122). Synaptic inputs are thought to trigger 
and synchronize this process throughout a population of cells which then might result in an 
epileptic fit. Several AEDs are GABA analogues, block GABA metabolism (e.g. vigabatrin, 
tiagabine, and valproate) or facilitate postsynaptic effects of GABA. However, a study 
evaluating dose-dependent behavioral effects of single doses of vigabatrin in audiogenic 
sensitive rats, suggests that the antiepileptic properties of vigabatrin not only depend on GABA-
ergic neurotransmission but might also be explained by decreased central nervous system levels 
of excitatory amino acids or increased glycine concentrations123. 
Glutamatergic synapses play a critical role in all epileptic phenomena. Activation of both 
ionotropic and metabotropic postsynaptic glutamate receptors is proconvulsant. Antagonists of 
N-methyl-D aspartate (NMDA) receptors are powerful anti-convulsants in many animal models 
of epilepsy. 
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Abnormalities of CNS catecholamines have been reported in several genetic models of 
epilepsy. In spontaneous epileptic rat, dopamine was decreased in the nucleus caudatus whereas 
noradrenaline was increased in midbrain and brainstem124. Decreased levels of dopamine have 
been found in epileptic foci of epilepsy patients125. In animal models of absence epilepsy, 
seizures are exacerbated by dopamine antagonists while fits are alleviated by dopamine 
agonists126. These results suggest that decreased dopamine facilitates appearance of seizures by 
lowering the threshold triggering such seizures. 
Periventricular heterotopia is an Xlinked dominant disorder of cerebral cortical 
development. Fox et al. (1998) showed that mutations in the filamin 1 gene prevent migration of 
cerebral cortical neurons causing periventricular heterotopy127. 
Affected females present with epilepsy whereas affected males die embryonically. 
Recently, however Recently, however, a male patient with bilateral periventricular and 
subcortical heterotopia was described which raises the possibility of a novel gene involved in 
brain formation 128. X-linked lissencephaly and double cortex syndrome is another disorder of 
neuronal migration. Double cortex or subcortical band  heterotopias often occurs in females 
whereas more severe lissencephaly is found in affected males. A causal mutation in a gene called 
doublecortin was recently identified129. It was suggested that doublecortin acts as an intracellular 
signaling molecule critical for the migration of developing neurons130. Although these disorders 
are relatively rare, studying the underlying pathophysiological mechanisms may shed light on the 
pathophysiology of more common epileptic syndromes.  
About 40% of patients suffering from epilepsy have a genetic background that 
contributes to the aetiology of epilepsy131. Most familial epilepsies like juvenile myoclonic 
epilepsy, childhood absence epilepsy, and benign childhood epilepsy with centrotemporal spikes 
have a complex mode of inheritance resulting from the interaction of  several loci together with 
environmental factors132. In patients with absence seizures (and their first degree relatives), 
biochemical changes (e.g. increased plasma glutamate levels) have been identified which can be 
related to a generalized increase in cortical excitability133. 
Probably, the genetic predisposition of absence epilepsy is based on a gene-dependent 
biochemical derangement leading to increased cortical excitability. Genetic data generated by 
studies on animal models of absence epilepsy show a relative simple inheritance factor of one 
gene that determines being epileptic or not while other genes determine number and duration of 
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epileptic fits134.  Monogenic epileptic disorders are rare, accounting for no more than 1% of 
patients. Recent advances in the genetics and molecular biology of these diseases unraveled the 
underlying Pathophysiology of some of these epileptic syndromes135.  
Although various epileptic syndromes were shown to differ pathophysiologically, they 
apparently share common ictogenesis-related characteristics such as increased neuronal 
excitability and synchronicity. Emerging insights point to alterations of synaptic functions and 
intrinsic properties of neurons as common mechanisms underlying hyper excitability. Progress in 
the field of molecular genetics revealed arguments in favor of this hypothesis as mutations of 
genes encoding ion channels were recently discovered in some forms of human epilepsy. 
 In most cases epilepsy treated with medications.  Over the past decades new drugs for 
epilepsy have became available which allow many people with epilepsy to live virtually seizure 
free lives. Anti-epileptic drugs do not cure the epilepsy they only control it136.  Most anti-
epileptic drugs exert their anti-epileptic properties through only a few neurochemical 
mechanisms that are meanwhile basic pathophysiological mechanisms thought to cause seizures. 
Pathophysiology of epilepsy and its underlying histological and neurochemical alterations has 
contributed to rational development strategies of new anti-epileptic drugs (AEDs). 
Antiepileptic drugs that are presently in clinical use include phenytoin, carbamazepine, 
ethosuximide, phenobarbitone, tiagabine, vigabatrin, gabapentin and clonazepam are the major 
drugs used for the treatment of epilepsy. The drug anti-epileptic drug phenytoin acts by blockade 
of voltage dependent sodium channels and stabilizes the neuronal membrane. It inhibits the 
generation of repetitive action potentials.  Voltage dependent Na+ channels enters an inactivated 
state and deley the recovery of these channels from  inactivation. AEDs have prominent side 
effects and fail to alter the course of epileptic complications. Dyskinesia, gingival hypertrophy, 
macrocytic anaemia, dermatitis, thyroiditis, taste disturbance, loss of appetite, dizziness, 
headache, flushing, increased urine output, gastro intestinal disturbance, skin rashes, drowsiness, 
over growth of  hair, acne, hair loss, constipation, diarrhoea, double vision, insomnia, attention 
difficulties, visual disturbance, cough, weight changes, abdominal pain are the adverse effect 
produced, which make more disturbance in medication periods of patients.  
Hence herbal drugs as therapeutic agents are preferred to reduce severe adverse effects of 
the allopathy therapy. Therefore, scientists are on the hunt for newer alternatives, with lesser side 
effects, self-administrable, less expensive and with complete reversibility. Much of these 
Evaluation of Anti-Epileptic Activity of Ethanolic Extract of Leaves of Cassia alata Linn. By 
Maximal Elecroshock (MES) and Isoniazid induced convulsions on mice 
 
Department of Pharmacology Page 75 
 
properties are observed in drugs of natural plant origin. Globally traditional system of medicine 
has been used to treat various diseases throughout the human history.  Many plants are reported 
to have anti-epileptic activity. Moringa oleifa(Moringaceae)137, Acorus calamus (Araceae)138, 
American ginseng (Araliaceae)139, 140 ,  Delphinium denudatum (Ranunculaceae)141-145 , 
Nardostachys jatamansi (Valerianaceae)146, 147,  Herpestis monniera (Scrophulariaceae)148, 149, 150  
,  Ambrosia paniculata (Asteraceae)151 are the some of the plants having anti-epileptic activity. 
In the present study the EECA was evaluated for its anti-epileptic activity in experimental 
mice.  Cassia alata Linn. used as purgative, expectorant astringent, vermicide and to treat all 
skin diseases. Cassia alata is one of the species that is now increasingly being used by herbalists 
as laxative, abortifacient; and in the treatment of various skin and respiratory diseases. The 
leaves of Cassia alata Linn. have been qualitatively analyzed for the presents of primarily five 
pharmacologically active anthraquinones: rhein, aloe-emodin, chrysophanol, emodin, and 
physcion152, as well as the flavonoid kaempferol153. Rhein and chrysophanol are known to be 
present in the roots154, in addition to two other quinine pigments155, These anthroquinone 
derivatives are well known to exhibit a variety of biological activities156, such as 
antimicrobial154, cytotoxic157, etc.  They are also claimed to possess other medicinal properties, 
hence their use by traditional healer in folk medicine. 
Acute oral toxicity studies revealed the non-toxic nature of the Cassia alata Linn. There 
was no lethality found at the dose of 2000mg/kg/p.o. which shows the safety of the plants. 
Flexion is the first stage in convulsive epilepsy, where the bending of joints, limbs occur.  
At this stage the rapid onset of a rigid posture with head flexed forwards, elevation of both arms, 
and flexion of the trunk forwards at the thigh. EECA treated animal shows significantly 
decreased in flexion period when compared to the untreated group.    
Extensor is the next stage followed by flexion, were limb extension occurs. Both flexion 
and extensor occur at very short duration. EECA treated animal shows significantly decreased in 
extensor period when compared to the untreated group. 
Clonus stage in seizures consist of bilaterally synchronous involuntary muscle jerks that 
results in singly or in a brief salvo of repeated jerks. EECA treated animal shows significantly 
decreased in clonus period when compared to the untreated group. 
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The maximal electroshock induced seizures produce repetitive stimulation of high 
frequency action potentials thus opening of Na+ channels and increasing Ca2+intracelluraly 
leading depolarisation of cell. It has been found out that treatment of mice with Cassia alata  
Linn. showed significant decrease in the hind limb extensor period. 
Animal models of seizures induced by electrical stimulation convey the advantage of 
reproducing epileptogenic features in the intact brain with low mortality and high 
reproducibility. Moreover, unlike chemical-induced seizures, postictal alterations from electrical 
stimulation can be investigated when the epileptogenic cause is no longer present. However, 
seizure modelling by electrical stimulation does not provide cell-type specificity in the brain. In 
addition, stimulation protocols can be costly and laborious when used for chronic studies158. 
GABA is an inhibitory neurotransmitter and glutamate is an excitatory neurotransmitter 
which is responsible for the production of excitation of neurons thus plays an important role in 
the generation of seizures. The Maximal Electro Shock (MES) induced seizure showed 
significant decreased levels of GABA in brain, thus showing that GABA plays an important role 
in the inhibition of seizures i.e., The percentage protection in the EECA with MES treated animal 
is significantly increased when compared to MES treated alone animal groups.  GABA level in 
EECA with MES treated group is significantly increased when compared to MES treated alone 
animal group.   
Rodents with spontaneous recurrent seizures have been generated by using chemo-
convulsants, primarily pilocarpine and kainic acid159. Usually, these models intend to mimic TLE 
(Temporal Lobe Epilepsy), and therefore rodents must display a similar “clinical history” as the 
human counterpart, including an initial precipitant injury afflicting the hippocampus and/or the 
temporal lobe (eg, status epilepticus [SE]), a latent period between the injury and the occurrence 
of spontaneous seizures, chronic manifestation of spontaneous seizures (usually partial and tonic-
clonic seizures), and histopathological changes deemed characteristic of TLE.157,160,161  
Inorder to study the Temporal Lobe Epilepsy and Status Epilepticus the INH induced 
epilepsy models are chosen. The compound is regarded as a GABA-synthesis inhibitor. Clonic 
tonic seizures are elicited in mice which is due decreasing in the pyridoxine metabolism. Due to 
decrease in the pyridoxine level, it produce the convulsion in mice.  The EECA and INH treated 
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animals showed significant decrease in the onset and decreased duration of the seizure when 
compared with INH alone treated group animals.  With that increased percentage protection from 
epilepsy in INH model shows that plant having anti-epileptic activity which can be used in TLE. 
The presence of Flavonoids may helps in the anti-epileptic property of Cassia alata Linn. 
The histopathological study of hippocampal region of brain shows that there is increased 
neuronal density produced by the EECA with MES treated groups compared to the MES alone 
treated group. The increased activity of GABA in EECA treated group may be due Inhibition of 
GABA transaminase enzyme or Inhibition of GABA transporter.  
And due to its anti-oxidant activity of Cassia alata, helpful to protect brain from toxicity, 
which can help from seizures and other epilepsy conditions77. 
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9. CONCLUSION:  
 The leaves of Cassia alata Linn. showed reduction in the flexion, extensor, clonus and 
stuper duration in MES induced epilepsy model. So the drug can be used in grandmal epilepsy. 
In INH model latency of epilepsy and lethality of animal was reduced. So the drug can be used in 
TLE. 
The histopathology of hippocampal region of brain showed normal architecture and there 
is increased neuronal density which is comparable with phenytoin. 
GABA level is increased, so the drug probably acts as GABA mechanism either 
Inhibition of GABA transaminase enzyme or Inhibition of GABA transporter.   
 Thus, it may be concluded that Cassia alata Linn. produces significant anti-epileptic 
activity in both MES and INH induced epilepsy in mice, which is comparable with that of 
phenytoin. Further work is necessary to elucidate the mechanism of action involved in the anti-
epileptic activity of Cassia alata Linn. with special reference to Phytochemical constituents. 
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